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Abstract 
 
Purpose: Healthcare policy increasingly emphasises the importance of including patients 
in treatment decision-making.  This review aimed to synthesise qualitative literature 
examining women’s experiences of treatment decision-making for early-stage breast 
cancer. 
 
Methods: Meta-ethnography was used to select and synthesise published qualitative 
research exploring women's experiences of treatment decision-making.  The quality of the 
literature was also assessed. 
 
Results: The search strategy yielded 18 studies.  Seven were excluded on the basis of 
quality appraisal.  The remaining 11 studies were synthesised.  Five themes were 
identified: women's role in decision-making, emotional impact of breast cancer, patient-
doctor relationship, managing information, and family and friends.  
 
Conclusions: Women experience decision-making as a dynamic, complex process that 
continues throughout diagnosis and treatment.  They may adopt different roles in decision-
making at different points in their care.  Treatment decisions are made in the context of 
women's emotional response to their breast cancer diagnosis.  Interpersonal relationships 
with healthcare professionals and family and friends are important.  Limitations and 
directions for future research are discussed. 
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Introduction 
 
Breast cancer is the most common cancer among women in the United Kingdom (UK), 
accounting for 30% of new cases in women (Cancer Research UK, 2012).  Women 
diagnosed with breast cancer face many treatment decisions over the course of their illness, 
including decisions about surgery, adjuvant treatments, and hormonal treatments.  The 
National Institute of Clinical Excellence Guidelines for early and locally advanced breast 
cancer (NICE, 2009) state that patients should have the opportunity to make informed 
decisions about their treatment, in conjunction with healthcare professionals.  In terms of 
surgical treatment, mastectomy and breast conserving surgery (BCS) are equally 
efficacious (Katz & Hawley, 2007).  It might be expected that more women would choose 
BCS where this is an option for them, but rates of BCS and mastectomy remain variable 
within the UK (Sauven et al., 2003).  Adjuvant treatments can have unpleasant side effects 
and may only have modest benefits for some women in terms of overall survival (Duric & 
Stockler, 2001).  Women must weigh up the potential benefits and harms of such treatment.  
The role of the patient in decision-making is therefore of interest.   
 
Current policy emphasises the importance of shared decision-making between patients and 
providers when deciding on treatments (The Scottish Government, 2010).  Shared 
decision-making can be defined as “a process in which clinicians and patients work 
together to select tests, treatments, management or support packages, based on clinical 
evidence and the patient’s informed preferences. It involves the provision of evidence-
based information about options, outcomes and uncertainties, together with decision 
support counselling” (Coulter & Collins, 2011, p.vii).  This is particularly important where 
comparable treatments are available or where outcomes are uncertain or risky.   In these 
cases, patient participation in decision-making allows decisions to be made that are 
consistent with their values and preferences (Broadstock & Michie, 2000).  In addition, 
there is some evidence that participation in treatment decision-making may reduce 
psychological morbidity.  For example, Hack, Degner, Watson and Sinha (2006) followed 
up 255 women with breast cancer for 3 years following surgical treatment.  Those who 
indicated they were actively involved in treatment decision-making had significantly 
higher quality of life than those who felt they had a passive role.  Similarly, a cross-
sectional survey of 636 women found that perceived involvement in treatment decision-
making for breast cancer was associated with better health-related quality of life at 2, 5 and 
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10 years post-diagnosis (Andersen, Bowen, Morea, Stein & Baker, 2009). 
 
Research on decision-making in cancer care has sought to understand patient preferences 
for involvement in decision-making and factors that may influence this, such as patient and 
physician characteristics.  Although shared decision-making is viewed as preferable, not all 
patients want to take an active role.  A review of 31 papers examining preferences for 
involvement in decision-making in people with cancer found that preferences vary 
considerably (Hubbard, Kidd & Donaghy, 2008).  While most people preferred a 
collaborative role in decision-making, a significant minority wanted a more passive or 
more active role.  There is also evidence to suggest that preferences for involvement are 
not always met.  Tariman and colleagues (2010) systematically reviewed 22 studies 
examining preferred and actual decision-making roles in people with cancer.  Across all 
cancer types, patients preferred a greater degree of involvement in decision-making than 
they experienced.  There was also evidence that role preferences changed over time.  These 
reviews demonstrate the difficulty in predicting patient preferences for involvement in 
treatment decision-making.   
 
A range of factors may impact preferences for involvement in treatment decision-making, 
including type and stage of cancer, age, and education level.  A literature review suggested 
that perceived risks and benefits of surgery, impact on body image and sexuality, and 
patient perception of surgeons' choices may impact on women's surgical decision-making 
for early-stage breast cancer (Sivell, Edwards, Elwyn & Manstead, 2010).  Jansen, Otten 
and Stiggelbout (2004) reviewed potential determinants of women's preferences for 
adjuvant therapy.  Although some patient and clinical characteristics predicted preferences, 
such as personal experience of treatment and having young children, preferences could not 
be fully explained by these factors.  The authors suggest cognitive and emotional factors, 
such as fear of recurrence, may be more salient.  In addition, they posit that some patient 
and clinical characteristics could have an impact through cognitive and emotional 
pathways – for example, patient perception of tumour size and its meaning to them, rather 
than the actual tumour size. 
 
Hubbard et al. (2008) note that findings regarding potential determinants of preference for 
involvement in decision-making are contradictory.  For example, some studies found no 
association between age and decision-making style, whereas others found younger age was 
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associated with more collaborative and active styles.  This may be due, in part, to the 
methods used to assess preferences.  Studies tend to use decisional preference scales (e.g. 
Degner et al., 1997).  A qualitative study investigating the process of answering structured 
questions about decision-making from patients' point of view (Entwistle et al., 2004) found 
that these are not always an effective measure of decision-making, as they do not reflect 
context and explanations for particular responses are not always consistent with the 
interpretation of the responses themselves.  
 
Real life medical decision-making is considerably more complex and may be influenced by 
a number of factors, including relationships with professionals, previous treatment 
experiences, patient concerns and social circumstances, as well as the interaction of these 
factors (Broadstock & Michie, 2000).  Context and emotional and cognitive factors may 
also play a role (Katz & Hawley, 2007).  Based on studies that found that achieving 
preferred involvement in treatment decision-making is associated with satisfaction 
regardless of surgical treatment received (e.g. Sabo, St-Jacques & Rayson, 2007), Katz and 
Hawley (2007) argue that the process of treatment decision-making is as important as the 
decision itself.  It is therefore important to understand how women with breast cancer 
experience and make sense of the decision-making process.  Qualitative research is well-
suited to developing a deeper understanding of their experiences. 
 
Qualitative research aims to explore in depth peoples' experiences and understandings 
(Ring, Ritchie, Mandava & Jepson, 2011).  Such approaches may explain conflicting 
findings from quantitative research and explain the interactions identified in these studies 
(Atkins et al., 2008).  Ring et al. (2011) argue that synthesising qualitative studies can 
make it easier to generalise findings.  This is particularly important in light of the 
increasing importance of considering the needs and preferences of service users in 
healthcare.  This review will therefore examine studies that have taken a qualitative 
approach to understanding women's experiences and perceptions of treatment decision-
making for breast cancer.  It will focus on the experiences of women with early stage 
breast cancer, as this the most commonly diagnosed stage (Cancer Research UK, 2012).  
Studies that address the overall experience of treatment decision-making or focus on a 
specific area (e.g. surgical decision-making) will be included.  This will help to build up a 
comprehensive picture of women's treatment decision-making, given that this is a complex 
process and there may be influences on decision-making across the whole illness 
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experience.  
 
 
Aim  
 
The aim of the present review is to explore women’s perceptions and experiences of 
treatment decision-making for early stage breast cancer by synthesising published 
qualitative research in this area.  A further aim is to examine the quality of studies. 
 
 
Review Question 
 
What is the experience of treatment decision-making for women diagnosed with early 
stage breast cancer? 
 
 
Methods 
 
Search strategy 
 
The Ovid interface was used to search the MEDLINE and Embase databases.  The 
EBSCOHost interface was used to search the PsychINFO and CINAHL databases.  The 
Web of Science database was also searched.  Searches were conducted in February 2015. 
 
A combination of subject headings and free-text terms was used to search each database.  
Search terms were clarified by a librarian.  The following terms were used: 
 
1.  breast neoplasms OR carcinoma, ductal, breast OR (breast adj2 (cancer* OR 
neoplasm* OR malign* OR tumo?r*)) 
 
AND 
 
2.  decision-making OR patient participation OR medical decision-making OR 
patient decision-making OR ((shared OR treatment OR patient) adj2 decision*)) 
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AND 
 
3.  qualitative research OR hermeneutics OR qualitative OR ethnograph* OR 
interview* OR narrative* OR experienc* OR perception* OR perceiv*  
 
The inclusion and exclusion criteria were used to sort the search results.  Reference lists of 
full-text articles retrieved for potential inclusion were hand searched for further references.  
The journal Psycho-Oncology yielded the highest number of relevant articles and was 
therefore hand-searched for relevant papers published in the last five years. 
 
 
Inclusion and exclusion criteria 
 
Inclusion criteria: 
 Studies exploring women’s experience of treatment decision-making for early stage 
breast cancer 
 Studies using qualitative methodology 
 Participants aged 16 or over 
 Studies published in peer-reviewed journals 
 
Exclusion criteria:  
 Case studies 
 Studies that only include women with recurrent or metastatic breast cancer 
 Studies that do not focus on primary treatment for early-stage breast cancer – for 
example, studies that focus on decision-making for preventative treatment  
 Mixed method studies 
 Studies examining decision-making for complementary and alternative treatments 
 Studies using quantitative methodology 
 Studies not published in English 
 
Although some papers included women with recurrent or metastatic breast cancer in their 
samples, the decision was made to include these where more than half the sample was 
women with early stage breast cancer. 
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Results of search strategy 
 
The results of the search are shown in Figure 1. 
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Figure 1: Flowchart detailing search strategy 
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Quality appraisal 
 
There is debate about application of quality criteria to qualitative research.  Some have 
argued that it should not be subject to quality appraisal, whereas others contend that tools 
specific to qualitative research can be usefully applied (Dixon-Woods, Shaw, Agarwal & 
Smith, 2004).  It has been suggested that the inclusion of poor quality studies may lead to 
poor quality meta-syntheses (Walsh & Downe, 2006).  In addition, the inclusion of good-
quality research allows policy-makers and practitioners to have confidence in the results of 
a review (Attree & Milton, 2006).  Therefore, it was decided to appraise the quality of 
studies eligible for inclusion in the present review and to exclude those judged to be of 
poor quality.  
 
Walsh and Downe’s (2006) criteria for appraising qualitative research was selected to 
evaluate the studies.  The authors drew on existing quality appraisal check-lists and 
frameworks to develop twelve essential criteria covering various aspects of qualitative 
research: clear statement of, and rationale for, research question / aim / purposes; study 
thoroughly contextualised by existing literature; method / design apparent, and consistent 
with research intent; data collection strategy apparent and appropriate; sample and 
sampling method appropriate; analytic approach appropriate; context described and taken 
account of in interpretation; clear audit trail given; data used to support interpretation; 
researcher reflexivity demonstrated; demonstration of sensitivity to ethical concerns; and 
relevance and transferability evident.  Full details of the framework, including specific 
prompts for each essential criterion, can be found in Appendix 2.  
 
To allow for evaluation and comparison of quality, studies were allocated 2 points if the 
criterion was fully met, 1 point if there was partial evidence and 0 points if there was no 
evidence that the criterion was met.  This gave a possible total score of 24.  Studies were 
rated as “good” if they received a score of 18 or more (75%), “adequate” if they scored 12 
or more (50%), or “poor” if they scored 11 or less (less than 50%).  An independent 
researcher rated the quality of the papers.  Agreement was 79% and disagreements were 
resolved through discussion.   
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Method of synthesis  
 
Meta-ethnography (Noblit & Hare, 1988) was used to combine the results of the studies.  
This involves translating the concepts of the studies into each other, in order to develop 
new interpretations. Meta-ethnography has a number of advantages.   Although there are 
various methods of combining qualitative data, Britten and colleagues (2002) argue that 
meta-ethnography is the most well developed method of synthesis.  It has been described 
in further detail by authors including Campbell et al. (2003) and Atkins et al. (2008).    
Meta-ethnography preserves the interpretive properties of the primary data.  It is a method 
that involves induction and interpretation, and therefore resembles the methods of the 
studies it aims to synthesise.  In this way, it can produce significant new insights on a given 
topic.  Meta-ethnography can allow for synthesis of studies with similar themes (a 
reciprocal translation) and those with contradictory themes (a refutational translation), 
although refutational syntheses are less well-described in the literature (France et al., 
2014).  In addition, it has been employed for syntheses in health care (e.g. Atkins et al., 
2008).  There is some debate about the suitability of meta-ethnography for synthesising 
studies from a wider range of qualitative methodologies (Dixon-Woods, Agarwal, Young, 
Jones & Sutton, 2004).  It was originally intended as a method for synthesising 
ethnographic research, and Jensen and Allen (1996) argue that it should only be used to 
synthesise studies within a single paradigm.  More recent research, however, has 
demonstrated that it is possible to employ meta-ethnography to synthesise studies from 
varying qualitative traditions (e.g. Campbell et al., 2003).  It was therefore decided that 
meta-ethnography was appropriate for the purpose of the present review. 
 
Meta-ethnography involves seven steps; these are described in Table 1 (based on Noblit & 
Hare, 1988 and Atkins et al., 2008).  Papers were synthesised in chronological order, to 
ascertain the impact, if any, of any changes in breast cancer treatments or decision-making 
practices over time.  
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Table 1: Process of meta-ethnography 
 
Step Description 
1 Getting started – defining a research question  
2 Deciding what is relevant to initial interest -  searching for studies and defining 
inclusion criteria; appraising quality of studies 
3 Reading the studies – becoming familiar with the studies and extracting themes 
and concepts 
4 Determining how the studies are related – considering the relationships between 
concepts and themes from each paper 
5 Translating the studies into one another – compare themes and concepts of 
paper one with those of paper two and the synthesis of these papers with paper 
three and so on. 
6 Synthesising the translations 
7 Expressing the synthesis 
 
 
Results 
 
The results of the quality appraisal are shown in Table 2.  Seven studies judged to be of 
poor quality were excluded from the synthesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
17 
 
 
 
Table 2: Results of quality appraisal 
 
Study Score (out of 24) Percentage Category 
Caldon et al. (2011) 20 83 Good 
Charles, Redko, 
Whelan, Gafni and 
Reyno (1998) 
16 67 Adequate 
Covelli, Baxter, Fitch, 
McCready and Wright 
(2015) 
19 79 Good 
Fang, Shu and Fetzer 
(2011) 
8 33 Poor 
Freedman (2003) 6 25 Poor 
Halkett, Arbon, Scutter 
and Borg (2007) 
21 88 Good 
Husain, Collins, Reed 
and Wyld (2008) 
16 67 Adequate 
Kenny, Quine, Shiell 
and Cameron (1999) 
10 42 Poor 
Kreling, Figueiredo, 
Sheppard, and 
Mandelblatt (2006) 
10 42 Poor 
Lally (2009) 16 67 Adequate 
Lam, Fielding, Chan, 
Chow and Or (2005) 
21 88 Good 
McVea, Minier and 
Palensky (2001) 
11 46 Poor 
O'Brien et al. (2008) 20 83 Good 
O'Brien et al. (2013) 18 75 Good 
Pierce (1993) 8 33 Poor 
Pieters, Heileman, 
Maliski, Dornig and 
Mentes (2012) 
19 79 Good 
Sheppard, Adams, 
Lamdan and Taylor 
(2011) 
11 46 Poor 
Weber, Solomon and 
Meyer (2013) 
17 71 Adequate 
 
The majority of studies partially or fully provided a rationale for the research.  One study 
failed to do this (Freedman et al., 2003).  Existing literature was used to contextualise the 
research by most studies.  Five papers (Fang et al., 2011; Freedman et al., 2003; Kreling et 
al., 2006; McVea et al., 2001; Pierce, 1993) did not do this – for example, they failed to 
link findings to previous research.  Reporting of method and design was variable.  Seven 
  
 
18 
 
papers did not adequately describe study design (Fang et al., 2011; Freedman et al., 2003; 
Kenny et al., 1999; Kreling et al., 2006; O’Brien et al., 2008; Sheppard et al., 2011).  Some 
papers gave a rationale for using qualitative methods but failed to state their 
epistemological or ontological grounding.  Data collection strategy was at least partially 
appropriate for most studies.  Only Fang et al. (2011) did not specify data collection 
strategy.  Three studies did not describe their analytic approach (Charles et al., 1998; 
Kenny et al., 1999; Kreling et al., 2006).  For the remaining studies, the analytic approach 
was partially or fully appropriate.  The appropriateness of analysis was difficult to judge 
where studies had not stated a qualitative method – for example, Weber et al. (2013) used 
the constant comparative method to analyse data but did not explicitly state that they were 
using Grounded Theory. 
 
Context was partially or wholly accounted for in all but two studies (Fang et al., 2011; 
Sheppard et al., 2011).  Studies omitted details such as who conducted interviews and 
where.  Four studies showed no evidence of a clear audit trail (Fang et al., 2011; Freedman 
et al., 2003; Pierce, 1993; Sheppard et al., 2011).  In seven studies, data was not used to 
support interpretation (Fang et al., 2011; Husain et al., 2008; Kenny et al., 1999; Kreling et 
al., 2006; McVea et al., 2001; Pierce, 1993; Sheppard et al., 2011) – for example, failing to 
provide quotes to illustrate themes.  Only two studies provided any evidence of researcher 
reflexivity.  Halkett et al. (2007) and O’Brien et al. (2008) referred to the use of reflective 
diaries by researchers, but did not explore the impact on the research.  The majority of 
studies reported sensitivity to ethical concerns, although it is striking that five studies did 
not state that they had received ethical approval (Freedman et al., 2003; Kenny et al., 1999; 
Lally, 2009; McVea et al., 2001; Pierce, 1993).  Lally (2009) carried out a secondary 
analysis of previously collected data, but did not state if ethical approval and participant 
consent had been sought for this.  Nearly all studies provided partial or full evidence of 
relevance and transferability.  Only two did not do this (McVea et al., 2001; Pierce, 1993).  
Studies tended to omit discussion of limitations and exploration of relevance to theory and 
practice. 
 
Table 3 describes the 11 studies selected for inclusion in the synthesis.  It should be noted 
that the studies by O’Brien et al.  (2008) and O’Brien et al. (2013) relate to different 
cohorts.
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Table 3: Characteristics of included studies 
 
Study Country Method Participant Characteristics  Themes 
Caldon et 
al. (2011) 
UK Framework 
approach 
Number 65 
Age range  33-73 years 
Cancer stage  Early stage breast 
cancer (stages not specified) 
Point in treatment  Following 
surgery – average time since surgery 
was 6 weeks 
 
Most reassuring treatment option 
 Safety and fears 
 Anecdotal information  
 
Least disruptive option 
 Minimise impact on life 
 Minimise psychosocial impact of surgery 
 
Information content and style 
 Contextual information 
 Framing of information 
 Accessibility of information 
 
Time and process of decision-making 
Autonomy  
Charles et 
al. (1998) 
Canada “Qualitative 
approach” 
Number 20 
Age range  42-78 years 
Cancer stage  Stage I and stage II 
(numbers in each group not 
specified)  
Point in treatment All women had 
already had surgery. Some were 
having consultations about adjuvant 
treatment and some had already 
begun treatment. 
Perception of choices for adjuvant treatment 
 The extent to which women perceive meaningful choices 
 
Weighing up benefits and risks 
 Developing lay constructions 
 
Patient’s role in decision-making 
 Taking action 
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Study Country Method Participant Characteristics  Themes 
Covelli et 
al. (2015) 
Canada Grounded 
theory 
Number 29 
Age Range 36-84 years 
Cancer stage  Stage I (n=15) 
                        Stage II (n=14)   
Point in treatment Completed – 
women had undergone mastectomy 
in the previous 9-12 months. 
 
Decision-making experience 
 Shock and fear at diagnosis 
 Discussion of treatment options 
 Sources of information 
 Understanding of recurrence and survival rates 
 
Reasons for mastectomy 
 Elimination of risk 
 
Post-operative outcomes 
 On-going physical and psychological concerns 
 
Taking control of cancer 
Halkett et 
al. (2007) 
Australia Hermeneutic 
phenomeno-
logy 
Number 18 
Age range  39-77 years 
Cancer stage  Stage I and stage II 
(numbers in each group not 
specified) 
Point in treatment Surgical and 
adjuvant treatments completed 
within previous year 
Decision-making characterised by five existential themes 
 Being challenged 
 Getting ready 
 Surviving 
 Sharing the challenge 
 Interrogating the future 
Husain et 
al. (2008) 
UK “Qualitative 
research 
methods” 
Number 21 
Age range 76-91 years 
Cancer stage Stage I and stage II 
(numbers in each group not 
specified) 
Point in treatment  Follow-up; time 
Attitudes toward cancer diagnosis 
Attitudes towards seeking treatment information 
Attitude towards surgery 
Attitude towards primary endocrine therapy 
Role of age 
Post-treatment experiences 
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Study Country Method Participant Characteristics  Themes 
from diagnosis ranged from 6 
months to 15 years 
Lally 
(2009) 
USA Grounded 
theory 
Number 18 
Age range 37-87 years 
Cancer stage Stage 0 (n=3) 
                       Stage 1 (n=11) 
                       Stage 2 (n=4) 
Point in treatment Before surgery; 
average of 12 days since diagnosis 
Treatment decision-making characterised by  
 Information processing 
 Contemplating options 
 Interacting with others 
Lam et al. 
(2005) 
 
 
 
Hong 
Kong 
Grounded 
theory 
Number 22 
Age range  23-88 years 
Cancer stage Stage 0 (n=5) 
                       Stage 1 (n=4) 
                       Stage 2 (n=8) 
                       Stage 3 (n=5) 
Point in treatment Post-surgical 
treatment; women were interviewed 
within 3 days of having surgery 
Four stages of decision-making: 
 
Causal conditions  
 Discovery of cancer 
 Emotional response to diagnosis 
 
Gamble of treatment choices 
 Uncertainty 
 Prioritising personal aims 
 Seeking and evaluating information 
 Time pressure 
 
Anticipated consequences of choices 
 Fear of death 
 Paying the price of treatment 
 Living in uncertainty 
 
Coping 
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Study Country Method Participant Characteristics  Themes 
 Keeping busy 
 Being optimistic 
 Believing in fate 
 Social comparison 
O’Brien et 
al. (2008) 
USA “Qualitative 
analytic 
techniques” 
Number  21 
Age range 34-79 years 
Cancer stage Early stage breast 
cancer (stages not specified) 
Point in treatment  Two groups of 
women – those having a surgical 
consultation (n=6) and those having 
an adjuvant consultation (n=15) 
Time since treatment N/A 
 
Four themes related to women’s perception of the treatment decision-
making process: 
 Information seeking about treatment options and resources 
prior to consultation 
 Most women identified a preferred and non-preferred 
treatment option prior to consultation 
 Information from the surgeon and family doctor was 
important to women’s subsequent decision-making about 
adjuvant treatment 
 Women considered different adjuvant treatment options using 
numerical information about recurrence 
 
Two themes related to women’s observations about their experiences: 
 Women valued physicians’ treatment recommendations 
 Some women did not expect to be offered a role in decision-
making 
O’Brien et 
al. (2013) 
USA Descriptive 
qualitative 
methods 
Number 19 
Age range 40-74 years 
Cancer stage Early stage breast 
cancer (stages not specified) 
Point in treatment Women were 
considering surgical treatment 
options (n=6) or adjuvant treatment 
Women described involvement in various stages of decision-making 
but not everyone described being involved in every stage.  The stages 
were: 
 Information gathering 
 Deliberating about options 
 Making the final treatment decision 
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Study Country Method Participant Characteristics  Themes 
options (n=13)  
Pieters et 
al. (2012) 
 
 
 
USA Constructi-
vist 
grounded 
theory 
Number 18 
Age range 70-94 years 
Cancer stage Early stage breast 
cancer 
Point in treatment Treatment 
completed within the previous 3 to 
15 months 
 
Instrumental relating (relating spontaneously) was used by women as 
a way to connect with others and to get the information they needed 
to make decisions.   
 Mutual caring for self and others 
 Ways of relating 
 Obtaining information 
 Interpreting healthcare providers 
 Deciding on trustworthiness of providers 
 Decision-making 
 Making the best decision 
 Making their own decision 
Weber et 
al. (2013) 
USA Constant 
comparative 
method 
Number 44 
Age range  33-69 years 
Cancer stage  Stage 0 (n=13) 
                        Stage 1 (n=9) 
                        Stage 2 (n=12) 
                        Stage 3 (n=5) 
                        Unsure (n=5) 
Point in treatment  Time since 
diagnosis ranged from a few months 
to 24 years 
 
Five decision-making styles were identified: 
 Medical expert 
 Self-efficacy 
 Relationship-embedded 
 Inhibition 
 Constellation of information 
 
These were underpinned by a continuum of  
 Low to high information needs; and 
 Self focus versus other focus 
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Meta-ethnography can lead to reciprocal translations or refutational translations.  The 
themes from papers in this review appeared to be similar and therefore gave rise to a 
reciprocal translation.  Five superordinate themes were identified: women's role in 
decision-making, emotional impact of breast cancer, patient-doctor relationship, managing 
information, and family and friends; these are explored below, with relevant quotes to 
illustrate.  A summary of the main themes and how they are represented in each study can 
be found in Appendix 3. 
 
 
Women's role in decision-making 
 
Across all studies, women adopted a range of treatment decision-making roles for 
themselves.  Some appeared to choose a passive role, preferring their doctor to make 
decisions for them as they perceived the doctor as the expert (see “patient-physician 
relationship”).  One woman stated: 
 
“No (I didn't ask questions), I just took it that they know what they're doing and 
that's it” (Husain et al., 2008, pg. 413) 
 
On the other hand, many women perceived that they had made the final treatment decision 
themselves, although their doctors had influenced the process of decision-making through 
the provision of information and opinion.  One woman described this as such: 
 
“And that was important for me too, to be informed.  Not just from one telling me 
this is what you should do.  Or this is what you shouldn't do.  But for me to know 
that having the medical team look at my charts and my files and present this … that 
was their recommendation.  Now the choice was mine to make.” (Charles et al., 
1998, pg. 83) 
 
A process of sharing decision-making was evident in the narratives of many women.  This 
was not always done with their doctors, but could encompass family or friends.  One 
woman described a decision making process that included her doctor and her husband: 
 
“Dr. [medical oncologist] presented us with the two treatment options …  So we left 
that day and even driving home I was thinking, well, I should probably go with the 
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Canadian one just because, I feel comfortable with that […] So I had to think about 
that for a bit, but, we had a week to decide on that  So we decided on that, on the 
Canadian regimen, last Friday.” (O'Brien et al., 2013, pg. 1721) 
 
For those that felt they had made the decision about treatment, either alone or in 
conjunction with others, this was associated with a feeling of taking control of their disease 
and their lives.  Pieters et al. (2012) reported that participants in their study made their own 
decisions, which were best for their individual circumstances; this allowed women to feel 
in control of their lives.  In another study, one woman commented: 
 
“I didn't want somebody to just tell me 'You're going to have it.'  I want to be in 
control, you know?  I have to be in control of what happens to me.” (Covelli et al., 
2015, pg. 387) 
 
Although none of the studies in this review examined decision-making longitudinally, 
women described changes in their thoughts about treatment decisions over time.  In three 
studies (Lally, 2009; O'Brien at al., 2008; O'Brien et al., 2013) women stated that they had 
preferences for particular treatments prior to consultations.  They tended not to share these, 
however, preferring to gather further information from their doctor and consider this before 
making a decision.  Halkett et al. (2007) reported that women in their study perceived 
treatment choices were made by their doctor, and thus were out of their control.  After 
decisions had been made, however, women began to recover a feeling of control by 
seeking further information about their treatment and the disease in order to fight it.  In 
addition, women were sometimes unprepared for involvement in decision-making and 
required time to adjust to this.  One woman described changes in her feelings about 
decision-making and the sense of control she experienced: 
 
“I've changed my mind as things have progressed … initially I was angry … I 
thought they should make the choice, they're the experts.  But now I'm glad that I 
had the choice because I've made the choice and I've got to live with it.  And I'm 
quite sure that I made the right choice.” (Caldon et al., 2011, pg. 1555) 
 
This suggests that women's role in treatment decision-making is evolving and dynamic and 
dependent on a range of factors at different points in their cancer journey.  These factors 
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are explored in the themes below. 
 
 
Emotional impact of breast cancer 
 
Ten studies identified the emotional impact of breast cancer diagnosis as a key factor in 
decision-making.  Several studies described the shock of diagnosis and the feelings of fear 
and anxiety this engendered.  One woman stated: 
 
“I was completely surprised and unprepared for the level of terror and horror that I 
felt; or how dreadful it is to be affected by it” (Halkett et al., 2007, pg. 325)   
 
For many women survival became a priority, and they wanted the treatment that they 
perceived would give them the best chance of surviving.  Women's treatment choices were, 
at least in part, driven by fear and worry.  Choosing the treatment that they felt would give 
the best chance of survival helped women to manage these emotions by providing a sense 
of reassurance.  One woman commented: 
 
“By having chemo and radiation I have done everything that I can do now […] 
you’ve done all the treatments, then you've taken every step you can … to protect 
your future” (Charles et al., 1998, pg. 78) 
 
This is perhaps particularly clear where women who had the option of mastectomy or BCS 
chose mastectomy, despite equal survival rates.  For example, one woman said: 
 
“I preferred a lumpectomy because of the changes in the shape of my body but I 
was afraid of recurrence.  I decided to have a mastectomy because the most 
important factor for decision-making about mastectomy, was that of recurrence” 
(Covelli et al., 2014, pg. 387)  
 
Worries about survival were also bound up in fear of cancer recurrence.  Against such 
emotional turmoil the choice of treatment became highly significant and many women 
continued to experience uncertainty about their future.  In some cases, this led to 
rumination about the treatment chosen and whether the right choice had been made. 
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“So, there's been the thought in my mind, did I make the right decision 
[lumpectomy] and I think I did.  But, I also have a tendency to try to go back and 
agonise over decisions.  But, I do keep coming back to the same spot, [which is] 
that I think I made the right decision.” (Lally, 2009, pg. E261) 
 
Other emotionally salient concerns were reported to impact upon treatment choice in some 
studies, including body image disturbance and side effects of further treatments.  Caldon et 
al. (2011) reported that some participants wavered between concern about body image and 
anxiety about surviving.  Some women described anxiety about adjuvant treatments, which 
impacted their decisions for surgery. 
 
“Avoiding the radiation was important but here was also possibility of chemo. Well, 
I chose the mastectomy so I didn’t have to do radiation.” (Covelli et al., 2015, pg. 
386)  
 
 
Patient-doctor relationship 
 
The majority of studies explored the impact of the doctor on women's decision-making.  
When women discussed doctors, they almost exclusively referred to surgeons and 
oncologists.  Within and between studies there was variation in how women described their 
relationship with their doctors and the role they perceived them as having in decision-
making.  Many women viewed their doctor as the expert on breast cancer, and therefore 
gave more weight to the information and advice they provided.  For example, one woman 
commented: 
 
“Well they are professionals.  They know more about it than I do.  I really don't 
know a damn thing about cancer” (Charles et al., 1998, pg. 83) 
 
Despite the perception of the doctor as an expert, the roles women wanted for doctors in 
decision-making were varied.  Some women thought that their doctor should be 
responsible for treatment decisions: 
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“I just left it in their hands, whatever they did was right, is how I felt.” (Husain et 
al., 2007, pg. 413) 
 
On the other hand, some women positioned the doctor as someone who could give them 
expert advice that would then enable them to make a decision about treatment themselves.  
One woman commented: 
 
“I wouldn't like the decision to come from a physician.  I think the physician can 
advise you … but it is up to you to take his advice … or to say no.” (Charles et al., 
1998, pg. 83) 
 
The expertise of the doctor was also related to their perceived trustworthiness, a factor 
which was important to many women.   
 
“I think the doctor was, the doctor and the person that actually read my MRI … for 
some reason the trust was there … I trusted him because I also heard very good 
things about him … I trusted he was doing what he needed to do.” (Weber et al., 
2013, pg. 415) 
 
Other significant qualities mentioned by women included warmth and empathy.  A sense of 
being cared for was important, and seemed to reassure women that their doctor would give 
them the best treatment possible.  The personal qualities of their doctor and the quality of 
the relationship they had with them were important.  For example: 
 
“When someone asks you “How are you?” you can see in their face that they really 
care; there's something about the eyes.  There's something like compassion, 
kindness, and when they explain things to you, they're gentle” (Pieters et al., 2012, 
pg. E15) 
 
Four studies noted that even where the doctor did not explicitly state an opinion on the best 
treatment option, some women attempted to identify this based on signs such as the order 
of presentation of treatment options (Husain et al., 2008; Lally, 2009; Lam et al., 2005; 
O'Brien et al., 2008).  Searching for an indication of their doctor's opinion may function as 
a way to manage the uncertainty of making their own treatment choice, by reassuring 
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women that the best choice had been made.  One woman described being reassured by the 
surgeon’s framing of treatment choices: 
 
“He told me that [mastectomy] is the standard treatment.  But it is also possible for 
me to preserve my breast if I want to.  I thought if [mastectomy] is the standard 
treatment, I should go for the standard one.” (Lam et al., 2005, pg. 8) 
 
 
Managing information 
 
Women in all studies gathered or received information from a range of sources, including 
medical professionals, friends, family, books, leaflets, and the internet.  Information was 
used throughout cancer journey.  The way in which women sought and used information 
varied within and between studies.  This suggested that women engaged in a process of 
managing information, by deciding how and when to seek and use it.  This depended to an 
extent on the personal meaning they attached to the information and the emotional salience 
of that information to the individual. 
 
Women received information about the various treatments available to them, including 
survival and recurrence rates, and risks and benefits of treatment.  They transformed the 
information they received to make it personally meaningful to them.  Women often 
developed highly idiosyncratic understandings of this information.  For example: 
 
“Beth: According to the surveys … the odds are better.  It [chemotherapy] reduces 
the chances of recurrence. 
 
 Interviewer: Do you know … 
 
Beth: From 70 per cent to 30 per cent … so that is a substantial difference.  So 
because of that you have to look at … ok … do I live 10 years or do I live 30 years, 
so take your choice!   Do you want to live or do you not want to live?  Some women 
might choose 10 [years] if they don't like their husband, they don't like their kids.” 
(Charles et al., 1998, pg. 81) 
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In the same study, a woman presented with identical figures did not view them as 
significant to her, stating “I know intellectually in my head the numbers don't mean a 
thing” (Charles et al., 1998, pg. 81).  Women's subjective conceptualisation of risk was 
therefore more important than the facts. 
 
Information could also be used as a way to cope – for example, by preparing to make 
decisions or preparing for treatment. 
 
“I think it's involved enough to know the information … give me the summary 
version so that way I can make a decision.  So I think, myself, I'm the type of person 
who likes information.” (O'Brien et al., 2013, pg. 1719) 
 
The emotional impact of information was closely tied to how women chose to use that 
information in their decision-making.  While some experienced information as reassuring, 
others found it fear-inducing.  Fear appeared to make information more salient.  This 
seemed to be particularly true of information pertaining to others' personal experiences of 
cancer and its treatment.  Hearing about others’ negative experiences made certain 
treatment choices more likely. 
 
“My aunt, she had a lumpectomy originally and the cancer came back.  That's 
when she decided to have the mastectomy.  So, she was like, 'Just do it.'” (Covelli et 
al., 2015) 
 
In order to manage the emotional impact of information, some women chose to avoid 
seeking it or using it.  One woman described feeling overwhelmed by information, and 
managing her emotions through avoidance: 
 
“If I don't like what I'm reading, I don't read it.  If I don't want to know the side 
effects of a drug, I don't read it … If I have to take it, I have to take it.  I'll deal with 
it as I'm taking it.” (Lally, 2009, pg. E259) 
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Family and friends 
 
The role of family and friends in women's decision-making was discussed in nine studies.  
Family and friends appeared to influence decision-making in direct and indirect ways.  In 
some cases, family members, particularly partners, had a direct role in decision-making – 
for example, they were present in the consultation or gave an opinion on what the woman 
should do.  One woman stated: 
 
“I mainly discussed with my family.  I asked my sisters … as both are nurses.  I had 
great confidence in (them).  I was so confused.” (Lam et al., 2005, pg. 10) 
 
They could also provide support and reassurance for women's decisions, even if they were 
not directly involved in making those decisions.  Halkett et al. (2007) noted that, for their 
participants, the support of others strengthened their sense of having made the best 
decision.  
 
Directly involving others in consultations and decision-making was problematic for some 
women, because others were unable to provide the required support or wanted support for 
themselves.  These women described having to manage the involvement of others.  They 
attempted to balance their need for support with others' needs.  One woman took her 
daughter to an oncology appointment to help her understand her decision not to have 
chemotherapy: 
 
“My daughter is [was] there and I says, 'I want you to hear that it's my choice.'  I 
said that so she can prepare herself for the fact that I am getting older.”  (Pieters et 
al., 2012, pg. E13)  
 
Family and friends could also have an indirect impact on women's decisions – for example, 
where women considered the consequences of their treatment choices for their 
relationships with others.  This is illustrated by one woman for whom family was the 
driving force behind her decisions: 
 
“Probably the biggest influence would be to be there for my kids.  That was the first 
thing that ran into my mind … I had to do this so I could be with them long term.” 
  
 
32 
 
(Weber et al.,  2013, pg. 416) 
 
Pieters et al. (2012) also reported that women in their study made decisions that took into 
account their wider responsibilities, such as caring for others.  Treatments that minimised 
the impact on their lives were favoured. 
 
 
Discussion 
 
Meta-ethnography revealed a range of themes across women's descriptions of making 
treatment decisions for early-stage breast cancer.  The results did not suggest a linear 
process of decision-making, but rather a range of factors that appear to operate 
dynamically throughout diagnosis and treatment.  Decisions took place in the context of 
women's emotional response to breast cancer, and their relationships with their doctors and 
significant others.   
 
The results of this synthesis are consonant with the conceptual model of women’s decision-
making for early-stage stage breast cancer proposed by Halkett, Arbon, Scutter and Borg 
(2005).  They suggest decision-making is determined by the emotional impact of diagnosis, 
previous knowledge of cancer, urgency, supportive others, information provided, body 
image and demographics.  They also include the role of the relationship between women 
and their doctors.  The synthesis adds support to this model, and extends the understanding 
of the important elements in women's decision-making.      
 
This meta-ethnography suggests that women adopt a variety of treatment decision-making 
roles, including passive, active and shared roles.  There was some evidence that these roles 
are dynamic and change over time, in response to different demands and concerns.  At 
times women made an active choice to assume a passive role or to avoid particular 
information, in order to cope emotionally.  Different models of decision-making have been 
proposed, such as informed decision-making, where patients use information provided by 
healthcare professionals to make their own decision, and paternalistic decision-making, 
whereby the doctor makes the decision (Charles, Gafni & Whelan, 1999).  Charles et al. 
(1999) propose a dynamic model of decision-making, in which decision-making styles can 
change within and between consultations.  Rather than label one way of making decisions 
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as “good” or bad”, they suggest the value of the approach should depend on patient and 
contextual factors.  This synthesis lends support to this conceptualisation of decision-
making as a complex, fluid process.  
 
The emotional impact of cancer was an important theme in women’s decision-making. The 
need to survive and fear of recurrence were particularly salient factors.  This is consistent 
with a systematic review which found that fear of recurrence was women’s predominant 
concern (Fiszer, Dolbeault, Sultan & Bredart, 2014).  Zikmund-Fisher, Fagerlin and Ubel 
(2010) posit that emotions may be more influential than facts in decision-making.  This 
was also evident in the theme “managing information”, which suggested that women's 
emotional response to cancer influenced their interpretation of information.  Some women 
may choose mastectomy instead of BCS, where this is an option, as they perceive 
mastectomy as a way to “get rid” of the cancer, and thus experience this as a more 
reassuring option.  
 
In addition, this meta-ethnography suggested that women engage in a process of managing 
information.  They appeared to use information to help them balance fear with hope.  
Women make sense of information in the context of their own lives, and decide what to do 
with that information.  A meta-ethnography of information-seeking during the cancer 
journey (Germeni & Schulz, 2014) supports this interpretation. Information-seeking 
behaviours changed over time, and participants could both seek and avoid information.  
This suggests that patients do not have static information needs, but rather engage in a 
dynamic process of managing information in response to their emotional and practical 
needs. 
 
Women’s decision-making took place in the context of relationships with others, 
particularly their doctors, family and friends.  Research consistently demonstrates that the 
relationship between patients and healthcare professionals is vital (Arora, 2003).  The 
results of this synthesis suggest that the role of the doctor goes beyond that of information-
giver.  The interpersonal relationship with the doctor is essential.  The perceived 
trustworthiness of doctors and their personal qualities made women feel cared for.  Given 
the emotional impact of breast cancer, feeling cared for may allow women to feel safe and 
reassured they are getting the best treatment possible.  Studies focusing specifically on 
doctor-patient communication lend support to this theme.  Wright, Holcombe and Salmon 
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(2004) found that women’s perception of doctors’ expertise was more important that the 
content of their communication.  Perceived expertise engendered trust in their doctors.  
Although information was important, the way in which it was delivered was more 
important; patients wanted doctors to do this in a way that maintained hope. 
 
Some research supports the importance of significant others in women's decision-making.  
Arora and colleagues (Arora, Rutten, Gustafson, Moser, & Hawkins, 2007) found that 71% 
of women with breast cancer in their study received helpful decision-making support from 
family at 2 months post-diagnosis.  Although this demonstrates that others are important in 
decision-making it does not determine how they influence the process.  The results of this 
synthesis suggest that they exert influence in direct and indirect ways, which may not be 
evident in a consultation – for example, where treatment is chosen to minimise impact on 
others.  Further research is need to examine how women and significant others perceive 
and negotiate decision-making. 
 
The influence of demographics was not evident in this synthesis.  Halkett et al. (2005) 
suggest that such factors could include age, education level, culture and geographical 
location.  It may be that participants in the included studies did not view these factors as 
relevant to their decision-making, or the content of particular concerns may vary 
depending on factors such as age.  For example, fertility may be a pertinent issue for 
younger women (Thewes, Butow, Girgis & Pendlebury, 2004).  The qualitative research 
reported here may tap into core processes of decision-making rather than the details of 
those processes. 
 
 
Researcher reflexivity 
 
As with primary qualitative research, it is important to consider the impact of the 
researcher on the synthesis of qualitative studies.  During the writing of this review, the 
researcher was conducting research into women's experiences between surgery and 
adjuvant treatment for breast cancer.  It seems likely that this would have affected the 
researcher’s interpretation of themes in the present synthesis.  As the researcher influences 
the synthesis, it is recognised that there may be other interpretations that are compatible 
with the included studies (Britten et al., 2002).   
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Limitations  
Only published studies judged to be of high quality were selected for inclusion.  It is likely 
that authors were constrained by limited word counts for journal publication.  Quality 
appraisal may therefore relate to the quality of the published report rather than the actual 
study.  To examine the impact of omitting poor quality studies, excluded studies were 
reviewed following completion of the synthesis.  The themes identified in these studies 
were concordant with the results of the synthesis.  For example, the emotional impact of 
breast cancer was present to some degree in all excluded studies.  This suggests that 
inclusion of poor-quality papers would not have added anything original to the synthesis.   
 
A number of methodological weaknesses should be addressed in future, to ensure that 
high-quality qualitative research is produced.  In particular, researchers should clearly state 
the qualitative method used and the analytic method employed.  Evidence of researcher 
reflexivity should be provided.  The decision to exclude papers that did not give details of 
the stage of cancer may have resulted in a loss of valuable information.  Without this 
information, however, the relevance and transferability of a paper cannot be adequately 
judged.  Sufficient demographic information should therefore be included in reports.  
 
The healthcare systems of different countries could have impacted women’s decision-
making.  Themes from studies conducted in different countries were synthesised, which 
suggests that there may be commonalities underpinning women’s decision-making.    
Alternatively, this may represent a limitation of the included studies, that they did not 
address the impact of the wider context on decision-making.  There are a number of ways 
in which cultural and political differences across healthcare systems in different countries 
could impact treatment decision-making.  Charles, Gafni, Whelan and O’Brien (2006) 
suggest that cultural differences can influence how illness is understood, how risk is 
understood, what is considered to be a good treatment outcome, what shared decision-
making means, what patients want to know about their disease, and who is involved in 
making treatment decisions.  Healthcare policies in different countries may mean certain 
treatments are available whereas others are not (Sinding & Wiernikowski, 2009).  
Healthcare policy may also impact on how shared decision-making is conceptualised and 
put in into practice, as well as the importance attached to it.  Other factors could include 
the cost of healthcare and whether this is free at point of contact or is paid for through 
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health insurance.  Sinding and Wiernikowski (2009) also point to the availability of health 
and social care services beyond the immediate treatment decision, and how these could 
influence patients’ decisions.  Interestingly, one of the studies excluded from the present 
synthesis on the basis of quality (McVea et al., 2001) examined the experiences of low 
socio-economic status women in Canada, but found that financial considerations were a 
minor aspect of participants' decision-making considerations.  Nonetheless, the impact of 
cultural and political differences on decision-making is an area that requires further 
investigation.   
 
It should also be noted that there was huge variety of time-points at which interviews 
occurred, both between and within studies.  For example, Lam et al. (2005) interviewed 
participants within 3 days of surgery, whereas time since diagnosis ranged from 3 months 
to 24 years for participants interviewed by Weber et al. (2013).  This could have a number 
of implications for the results.  It is possible that healthcare practices and treatments could 
have changed over time, which could impact on the interpretation of the results.  Recall of 
the decision-making process may be impacted by the length of time since treatment, 
although Blane (1996) argues that highly significant events are not necessarily recalled 
inaccurately.  The outcome of treatment could also bias participants’ responses – for 
example, if they are satisfied with the outcomes, they may reflect more positively on their 
experiences.  The results of the present synthesis should therefore be interpreted in light of 
these contextual factors.   
 
Finally, it is possible that combining studies that vary in stage and type of treatment and 
time point of interview may have resulted in a loss of richness of detail regarding particular 
treatments or points in treatment.  The similarity of themes across the studies, however, 
suggests that there is value in synthesising such varied studies.  Several papers reported 
that decision-making appears to be an iterative process that continues throughout the 
cancer journey (Charles et al., 1998; Halkett et al., 2007; Lally, 2009; O’Brien et al., 2008; 
O’Brien et al., 2013).   
 
 
Implications 
 
The present findings have a number of implications for research and clinical practice.  
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Decision-making is a complex, dynamic process and medical professionals should aim to 
respond flexibly to women’s needs (Charles, et al., 1999).  Additionally, women may need 
more time to consider their options, given the emotional impact of a breast cancer 
diagnosis.  Medical practitioners should also assess women’s understanding of information 
and its personal relevance to them, in order to ascertain the impact on their decision-
making. 
 
In terms of future research, only two studies in this review mentioned the role of other 
healthcare professionals, such as breast care nurses, in women's decision-making (Halkett 
et al., 2007; Lally, 2009).  Women may not perceive other professionals as having a role in 
decision-making, or researchers may not have explored this in sufficient detail.  Further 
research could address this area.  In addition, some studies included women with recurrent 
or advanced stage disease, but failed to examine if this was a factor in decision-making.  
As prognostic information and treatment options will differ for women with advanced 
stage disease, qualitative research focusing specifically on decision-making in this group 
would be useful.  Given the importance of the doctor-patient relationship, factors specific 
to the clinician will also be important, such as personal preference and the influence of 
medical guidelines (Halkett et al., 2005).  Research could therefore examine how medical 
professionals perceive and manage decision-making in breast cancer treatment. 
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Plain English Summary 
 
Title:  A qualitative investigation of the experiences of women with breast cancer between 
surgery and adjuvant therapy 
 
Background:  Information about treatment and good communication with healthcare 
professionals is important to people with cancer.  These can help people to feel less 
distressed and may also improve engagement with treatment.  Adjuvant treatment is 
treatment that helps other treatments be more effective.  They are usually given after 
surgery.  These treatments can include chemotherapy and radiotherapy.     
 
Aims and Questions: The aim of this paper was to explore the experiences of women with 
breast cancer in the time between surgery and chemotherapy or radiotherapy.  It also aimed 
to explore their views of communicating with the healthcare staff involved in their care, 
and their expectations of further treatment.  
  
Method: Participants were women with breast cancer who had had surgery and were due 
to receive either chemotherapy or radiotherapy.  They were asked to participate by their 
breast care nurse after their treatment was confirmed.  Participants met with the researcher 
and semi-structured interviews were carried out.  These were audio-recorded.  Five women 
were interviewed in total.  Two women were scheduled to receive chemotherapy and three 
to receive radiotherapy.   
 
Main Findings: Participants’ experiences were grouped into four main themes: uncertainty 
about adjuvant treatment, adjustment to cancer, knowing enough, and relationships with 
healthcare professionals. 
 
Conclusions:  The time between surgery and adjuvant treatment was a time of uncertainty 
for participants.  They were anxious about having chemotherapy or radiotherapy, and 
worried about the potentially unpleasant side effects.   Although they were anxious, it 
seemed that some uncertainty also helped women to stay hopeful that their treatments 
might not be as unpleasant as they expected.  Women also continued to come to terms with 
their diagnosis of cancer in this time period.  This shows that they have a lot to cope with 
at this time.  Women wanted to know enough about treatment to prepare themselves, but 
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did not want to be overwhelmed with information.  Women made efforts to seek 
information that was useful or helpful and avoid information that was upsetting.  
Healthcare staff were viewed as a trustworthy source of information.  These relationships 
supported women's coping at this point in time.  This study shows that it is important for 
healthcare staff to listen to women’s individual needs at this point in time. 
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Abstract 
 
Objectives: The aim of this paper was to explore the experiences of women with breast 
cancer in the period between surgery and adjuvant chemotherapy or radiotherapy.  It also 
aimed to explore their perceptions of communicating with the professionals involved in 
their care, and their expectations of adjuvant treatment. 
 
Design: Qualitative data were collected through in-depth semi-structured interviews   
 
Methods: Five women were interviewed following surgery and prior to starting adjuvant 
treatment.  Two women were scheduled to receive chemotherapy and three to receive 
radiotherapy.  Interviews were audio-recorded, transcribed verbatim and analysed using 
Interpretative Phenomenological Analysis. 
 
Results: Four themes were identified: uncertainty about adjuvant treatment, adjustment to 
cancer, knowing enough, and relationships with healthcare professionals. 
 
Conclusion: The period between surgery and adjuvant treatment was characterised by 
uncertainty.  This may be adaptive at this point, as it allowed women to maintain hope in 
the face of potentially unpleasant treatments.  Women also continued to adjust to their 
diagnosis.  They wanted to know enough about treatment to prepare themselves, but did 
not want to be overwhelmed.  Women emphasised their own agency in managing 
information.  Healthcare professionals were viewed as a trustworthy source of information, 
and these relationships supported women's coping in this time period.  This study 
underscores the importance of responding flexibly to women's information and 
communication needs during treatment.  
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Introduction 
 
Research suggests that individuals with cancer use information as a means of coping with 
their illness – for example, by supporting involvement in treatment and reducing distress 
(Mills & Sullivan, 1999).  A review of 112 papers examining the information needs of 
cancer patients found that need for information was particularly high during diagnosis and 
treatment.  Healthcare professionals were found to have a key role in providing 
information, although other sources, such as written information, the internet, and friends 
and family were also important (Rutten, Arora, Bakos, Aziz & Rowland, 2005).  The most 
common factors found to contribute to patients' overall satisfaction with care are level of 
information given and interpersonal relationship with the provider.  Satisfaction with care 
is associated with better co-operation with treatment, which is in turn associated with better 
clinical outcomes (Sandoval, Brown, Sullivan & Green, 2006).  Sandoval and colleagues 
found that areas consistently rated as problematic by patients with cancer included: 
information about follow-up care, knowing the next step in treatment, and knowing who 
was available to answer their questions. 
 
Cancer care can be conceptualised as a trajectory or pathway, comprising a number of 
stages. Morse & Fife (1998) delineate five key stages, including diagnosis, end of primary 
treatment, remission, relapse, and palliative care.  Evidence suggests that patients' needs 
vary at different stages of their illness (Rutten et al., 2005).  Investigation of 
communication in cancer care is further complicated when patients receive various 
treatments from a number of professionals in a range of settings.  National policy (Scottish 
Government, 2008) emphasises the importance of support for people throughout complex 
care pathways, and the centrality of good information in reducing uncertainty about care 
and treatment.  Qualitative methods may therefore be especially suited to examining 
patients' experiences and understanding the dynamic nature of their information needs and 
preferences.   
 
 
Breast cancer 
 
A number of studies have focused on the communication and information needs of women 
with breast cancer.  This is an important area of research as breast cancer is the most 
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commonly diagnosed cancer in women in the United Kingdom (UK). The main treatments 
are surgery, chemotherapy, radiotherapy, hormone treatment and biological therapy; these 
can be used in isolation or in combination (NICE, 2009).   
 
Quantitative and qualitative research indicates that information is important to women with 
breast cancer.  A literature review (Rees & Bath, 2000) regarding the specific information 
needs of women with breast cancer found that women's greatest need during surgical and 
adjuvant therapies was for information about their treatments. Verbal information from 
healthcare professionals was the preferred source of information, although other sources, 
such as written information, were used.  There is evidence that women’s needs change over 
the course of their illness.  A cross-sectional questionnaire based study (Raupach & Hiller, 
2002) assessed the information needs of 266 women with breast cancer between 6 and 30 
months post-diagnosis.  They found a continued high need for information regardless of 
time since diagnosis.  The results also suggested that this need was often unmet, and that 
information giving decreased over time. In contrast, a longitudinal study by Vogel, Bengel 
and Helmes (2008) found that women (n = 135) reported the highest information needs at 
the beginning of treatment, compared to 3 and 6 months follow-up.  These studies suggest 
that women's information needs are high and may change over time but it is not clear why 
these change.   
 
Other studies have adopted a qualitative approach. Thomsen, Pedersen, Johansen, Jensen 
and Zachariae (2007) interviewed 15 women with breast cancer about specific positive and 
negative communication experiences from their treatment 3 months after completion of 
adjuvant chemotherapy. Information giving and the meeting of emotional needs were key 
themes arising from the data analysis. The authors note that the relatively long gap between 
the end of treatment and interview, however, may have led to recall bias. Stephens, 
Osowski, Fidale and Spagnoli (2008) interviewed 200 women newly diagnosed with breast 
cancer who had recently received surgery.  They identified a number of needs including the 
social, emotional, physical and spiritual needs. Participants also expressed anxiety about 
future treatments. 
  
Qualitative and quantitative studies reveal conflicting results with regards to breast cancer 
patients' experiences of communication and information giving. Some studies have used 
relatively heterogeneous samples (e.g. a mixture of stages and types of cancer), which may 
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mask differences between patients with different cancers.  The literature to date suggests 
that women’s needs and experiences are dynamic and complex.  Birchall, Richardson and 
Lee (2002) assert that the complexity of patient experiences may not be adequately 
captured by questionnaires, as these can often show a positive response bias and may 
constrain the responses people give on a topic.   
 
 
Adjuvant treatment 
 
Some research has examined the particular needs of women undergoing adjuvant 
treatments. Lerman et al. (1993) surveyed 97 women after surgery but before adjuvant 
treatment, and 3 months later. Most women experienced difficulties comprehending 
information and asking questions prior to adjuvant treatment.  Communication problems at 
the first time point were associated with greater distress at follow-up.  Graydon et al. 
(1997) used a questionnaire to assess the information needs of three groups of women with 
breast cancer at different stages in treatment (surgery, chemotherapy and radiotherapy). 
Each group reported a strong need for information, with no significant differences between 
the groups.  Difficulties reported with getting information may relate to relationships with 
healthcare professionals, difficulties retaining information, and having too much 
information to take in (Skalla, Bakitas, Furstenberg, Ahles, & Henderson, 2004).   
 
Evidence suggests that patients receiving chemotherapy experience considerable distress 
(DiLorenzo et al., 1995). The highest level of anxiety has been found to occur prior to the 
first treatment, perhaps because of patient expectations about chemotherapy (Jacobsen, 
Bovberg & Redd, 1993).  Similarly, a literature review found that anxiety is generally 
highest before the first radiotherapy treatment (Stiegelis, Ranchor & Sanderman, 2004).  
Buick et al. (2000) compared women receiving chemotherapy with women undergoing 
radiotherapy at five time points before, during and after their treatment.  Although patterns 
of distress for each therapy diverged over the course of treatment, both groups of women 
experienced similar levels of distress before treatment began.  The authors suggest that the 
period between surgery and adjuvant treatment may be particularly stressful for women.  
Research tends to focus on women’s experiences before or after treatment is completed.  
Receiving treatments such as chemotherapy and radiotherapy may be particularly stressful 
for women, as these have a number of unpleasant possible side-effects.  Mishel’s (1990) 
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uncertainty in illness theory proposes that uncertainty can be increased by illness events 
that are vague, ambiguous, unfamiliar, unpredictable, and complex.  The healthcare 
environment can also contribute to uncertainty – for example, where treatments take place 
in different settings and a range of professionals are involved.  Interviewing women in the 
period between surgery and adjuvant therapy may allow for a deeper understanding of the 
dynamic nature of their experiences at this point, when uncertainty and distress may be 
high.  
 
 
West of Scotland Context 
 
In the West of Scotland women diagnosed with breast cancer are usually seen by their 
surgeon first. Following surgery they are under the care of the Beatson West of Scotland 
Cancer Centre (BWoSCC) for adjuvant treatment, although they may be seen at satellite 
clinics in local hospitals for oncology appointments. Communication and information 
sharing may be particularly important during this period, as these may impact on women's 
expectations of adjuvant therapy and subsequent engagement with treatment. Women's 
experience of transition between the two phases of treatment is therefore of interest. To the 
author's knowledge, no studies have examined transitions in breast cancer care in Scotland.   
 
In summary, research consistently suggests that information and communication are 
important in cancer care for a number of reasons including minimising patient distress and 
improving engagement with treatment. Difficulties with communication may have 
psychological consequences for patients. Care pathways can be complex and it seems 
likely that experiences will differ at each time point. Closer attention to different points in 
the cancer journey is therefore warranted. 
 
 
Aims 
 
 To gain insight into the experiences of women with breast cancer, particularly their 
experiences in the time between surgical and adjuvant treatments.  
 To explore the expectations women have of adjuvant treatment. 
 To explore their perceptions of communicating with the different professionals 
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involved in their care in order to gain more detailed information about their needs 
between these stages of treatment.  
 
 
Methods 
 
Design 
 
A qualitative approach was used to understand women's experiences of the period between 
surgery and adjuvant treatment.  Interpretative Phenomenological Analysis (IPA) was 
employed. Smith, Jarman and Osborn (1999) suggest that IPA is particularly appropriate 
for health psychology research. It involves 'the detailed examination of personal lived 
experience, the meaning of that experience to participants and how participants make sense 
of that experience' (Smith, 2011, p. 9). IPA also emphasises the role of interpretation by the 
researcher during analysis.  
 
 
Sample 
 
There are a number of different care pathways for women, depending on type and stage of 
cancer and treatment options. A purposive, well-defined homogeneous sample was 
recruited in terms of stage of breast cancer and treatment pathway, to allow detailed 
examination of similarity and variability within the sample (Smith, Flowers & Larkin, 
2009).  
 
Inclusion criteria:  
 Women with primary early-stage breast cancer who had surgical treatment (such as 
mastectomy or breast conserving surgery) and were scheduled to receive adjuvant 
chemotherapy or adjuvant radiotherapy.   
 Some women may have had both treatments; the focus of this research was on the 
first adjuvant treatment women received following surgery. 
 
Exclusion criteria: 
 women under 30 years old – there is a steep increase in age-specific incidence rates 
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from the ages of 30 – 34 onwards (Cancer Research UK, 2014). This was to allow a 
more homogeneous sample to be recruited. 
 those for whom English was not their first language 
 women who had started their adjuvant treatment 
 women with a prior history of cancer  
 those who had received chemotherapy or radiotherapy prior to surgery 
 women who had a biopsy only 
 women with ductal carcinoma in situ (DCIS), as research suggests that the 
experiences of these patients may be different (e.g. Kennedy, Harcourt & Rumsey, 
2012) 
 
IPA studies are typically based on small samples (Smith, 2011). Braun & Clark (2013) 
suggest a suitable sample size for an IPA study is small / moderate but large enough to 
convincingly demonstrate patterns across a data set.  Smith et al (2009, p.52) have 
suggested that 4-10 interviews are suitable for studies conducted as part of a professional 
doctorate. Generalisability is not the aim of qualitative research; rather, the aim is to 
generate detailed accounts of individual experience.  Smith et al. (2009, p.49) also state 
that IPA researchers usually try to find a fairly homogeneous sample for whom the research 
question will be meaningful. 
 
Recruitment took place between December 2014 and June 2015.  Five women were 
interviewed.  The age range of participants was 44 – 71 years.  Four women had breast 
conserving surgery and one had mastectomy.  Two women were scheduled to receive 
chemotherapy and three were due to receive radiotherapy.  Three women agreed to initial 
contact with the researcher but did not respond to follow-up contact.  Two women agreed 
to contact with the researcher but did not meet inclusion criteria. 
 
 
Ethical considerations 
 
The study was approved by the West of Scotland Research Ethics Committee (Appendix 3) 
and NHS Greater Glasgow and Clyde Research and Development Management (Appendix 
4).   Approval for amendments to widen the inclusion criteria to include women having 
radiotherapy and to add recruitment sites was also granted (Appendices 5, 6 and 7).  
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Confidentiality was explained to all participants and written consent was gained before the 
interview commenced (Appendix 8).  Participants were informed that they could withdraw 
at any point, with no impact on their medical care. 
 
 
 
Recruitment 
 
Women were identified by their breast care nurse at their first or second oncology 
appointment at the BWoSCC, Vale of Leven Hospital or Royal Alexandra Hospital 
following confirmation of their adjuvant treatment plan.  Women identified as suitable 
were told about the study by their nurse, who gave them an information pack (Appendices 
9 and 10) and invited them to contact the researcher if they wished to participate or to ask 
further questions.  The decision about who to give information packs to was made by the 
breast care nurses, and the researcher had no contact with potential participants who did 
not receive information packs.  
 
Telephone interviews were offered to all participants. It has been suggested that telephone 
interviews could result in the loss of non-verbal information, which could impact on data 
analysis; telephone interviews may, however, allow participants to feel comfortable and to 
disclose sensitive information (Novick, 2008). Sturges and Hanrahan (2004) found no 
significant differences in data quality between telephone and face to face interviews.  One 
participant chose this option.  There was no discernible impact on interview length or 
quality. 
 
 
Research procedures 
 
A semi-structured interview schedule was developed to facilitate the interview (Appendix 
11). Relevant background research and discussion with supervisors and clinicians was used 
to develop the interview guide.  The first interview was reviewed by the author and 
supervisors to ensure that the required information was elicited.  The interview schedule 
was judged to be appropriate and was used in further interviews without modification.  
This interview was included in data analysis. 
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Interviews took place in a quiet room at the BWoSCC or the participant’s local hospital.  
Interviews lasted between 40 and 59 minutes.  Interviews were audio-recorded, transcribed 
verbatim, and then checked for accuracy and completeness.  All interviews were 
anonymised for references to person or place.   
 
 
Researcher reflexivity 
 
The interpretative element of IPA involves acknowledging the role of the researcher and 
how their background and beliefs may influence data collection and analysis.  The 
researcher had no personal or professional experience of women with breast cancer.  
Alongside data collection and analysis the researcher was carrying out a systematic review 
of women's experiences of making treatment decisions for breast cancer.  This may have 
biased the analysis of the interviews, by making some themes more salient.  Following 
completion of each interview, the researcher recorded reflections on the interview and any 
initial ideas, impressions or feelings.  The researcher also kept a reflective diary during 
data analysis, in order to consider sources of bias and the impact these may have had on 
emerging themes. 
 
 
Data analysis 
 
Analysis began while recruitment was on-going.  The first stage of analysis, as described 
by Smith et al. (2009), involved reading the transcript several times to become as familiar 
as possible with the data.  In stage two, anything of interest in the transcript was noted.  
This included descriptive comments, which describe or summarise participants’ accounts, 
language-based comments which attended to participants' use of language, and initial 
interpretations of the data.  In the third stage of analysis emergent themes were developed 
from the initial notes. These were given a title or phrase to summarise the essence of the 
theme. Connections across the emergent themes were then explored, generating super-
ordinate themes.  Following analysis of each interview transcript, patterns and connections 
across interviews were explored.  Super-ordinate themes were discussed in research 
meetings and two interview transcripts were analysed blind by the academic supervisor to 
  
 
57 
 
ensure the plausibility of the analysis (Smith et al., 2009, p.80).  An excerpt from one 
interview can be found in Appendix 12.  
 
 
 
 
Results 
 
Four super-ordinate themes were identified; these are shown in Table 1, with sub-themes 
where these were identified.  Pseudonyms are used throughout. 
 
Table 1: Themes  
 
Super-ordinate Themes Sub-themes  
Uncertainty about treatment  Anxiety about side-effects 
 Preparation and avoidance 
Adjusting to cancer   Staying positive 
 Staying normal 
 Staying present 
 Friends and family 
Knowing enough  
Relationships with healthcare 
professionals 
 
 
 
Uncertainty about treatment 
 
Anxiety about side effects 
 
All participants stated that they had been made aware of the possible side effects of 
treatment by their doctors, and referred to specific effects that had been discussed or 
leaflets they had been given detailing these.  Women expressed anxiety about the potential 
side effects of treatment.  Lucy explained some of her concerns about having 
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chemotherapy: 
 
“But my – the only thing is you read through all the possibilities, and you’ve got to 
 read them because they’ve got to tell you about the side effects that the 
chemotherapy can have and you’re thinking -  It does go through your head.  You 
know, somebody I know, their fingernails and their toenails – and I know it doesn’t 
happen to everybody  – but even they fell off and I thought “ah, I don’t know if I’d 
like that”.” (Lucy)   
 
For women having chemotherapy, hair loss and nausea were particular concerns.  Concerns 
were also discussed by women who were scheduled to receive radiotherapy.  These related 
particularly to tiredness and the possibility of being burned.  Angela's language vividly 
conveys the fear she feels regarding potential side-effects.  Her statement about the 
necessity of having adjuvant treatment seemed to help her manage some of these anxieties.   
 
“but you know, I don’t want to get burnt, and I don’t want all the horrible things 
that happen.  And I am anxious to come here every day.  It’s going to be quite a 
trauma to come up here every day.  But, em, it’s all for the good of me, so there’s a 
light at the end there for me” (Angela) 
 
May's vivid description of the treatment process conveys her understanding of the impact it 
can have:  
 
“Eh the surgery’s only one bit of it […] the cancer’s gone but there’s still the 
potential for recurrence, and so the – the chemotherapy is really standard 
treatment.  I think I’ve read somewhere it’s eh “slash burn” and eh what’s the third 
thing?  “Poison” [laughs] “Slash, poison and burn” – that’s it!  So you’ve got the 
surgery and then you’ve got the chemotherapy and then you’ve got the 
radiotherapy.” (May)  
 
All women said that they still felt healthy.  The contradiction of having treatment when 
they felt well seemed to heighten women’s uncertainty about adjuvant treatment.  This was 
amplified following surgery to remove the tumour.  Sam described her feelings of shock 
that the tumour had been removed: 
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“I felt – one minute I had been told I had cancer and the next minute it’s kinda -  
And I know – I feel, I feel it won’t be totally gone until, you know, I complete my 
 radiotherapy, but then I know it has gone but I think actual – that I’ll be able to say 
 that I’m cancer free until I’ve finished all my treatment, if you know what I mean.” 
 (Sam) 
 
 
Preparation and avoidance 
 
Women appeared simultaneously to prepare for the possibility of treatment side-effects and 
minimise the possibility of experiencing these.  All participants discussed potential side-
effects but stated that these might not happen to them.  For example, Lucy had prepared for 
chemotherapy by buying a wig and had made other practical preparations, including 
buying a thermometer and a soft toothbrush.  On the other hand, she stated: 
 
“But still in my head I’m thinking, no two people are the same, so that might not 
 happen to me, or that might not happen to me.  So, there’s no point in me thinking 
that I’m going to get all this big list of things, cause I might only get two or three or 
four of them.  Cause there is a big list of possible things [laughs] but I might only 
get a few of them, so.” (Lucy)  
 
In preparation for radiotherapy, Carol said that her family would share responsibility for 
caring for her grandchildren during her treatment in case she was too tired.  She later stated 
that tiredness was normal for her.  This seemed to be a way to negate any additional fatigue 
as a result of radiotherapy.  In this way, she appeared to both prepare for treatment and 
downplay the possibility that she would experience the side-effects. 
 
“But you don’t know what like it is til you – you don’t know what like something is 
til you get it yourself.  That’s just the way I feel, so just need to take each – each day 
as it comes.  And they say – they say that you get tired with radiotherapy, but I get 
tired quite a lot – that’s part of my life.” (Carol) 
 
The way in which women acknowledged potential side-effects but minimised the 
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possibility of these happening to them seemed to actively maintain uncertainty.  In turn, 
this seemed to help women maintain hope that treatment would not be as bad as they 
feared. 
 
 
 
Adjustment to cancer 
 
All women referred to the speed with which they had been diagnosed and commenced 
treatment.  Whilst all participants felt this was positive as it meant the cancer was being 
treated, it seemed that they had multiple demands on their coping resources at this point in 
time, including managing the shock of diagnosis and learning about further treatment and 
prognosis. 
 
The shock of diagnosis was a recurrent theme in all participants' narratives.  This suggests 
that at the time of interview women continued to try and adjust to their diagnosis.  For 
example, Angela commented: 
 
“I was in denial.  Cause I had no lump.  And to be told or not to be told, ehm 
[pause] that I – I had it, and I thought, how does that work?  You know I don’t 
believe there’s anything wrong with me” (Angela) 
 
Her switch to the present tense suggests that she continued to process the shock of her 
diagnosis.  Angela's cancer was asymptomatic, but women who had a lump or other 
symptoms also experienced shock at their diagnosis.  May stated: 
 
“So I - I had a feeling I was in trouble anyway [laughs] because of the fact I had 
had this lump for a while and just [pause] thought well it can’t be cancer, but it 
was.”  (May) 
 
 
Staying positive 
 
All women emphasised staying positive as a means of coping with their diagnosis and 
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subsequent treatments.  For some women, this meant finding the positive in their diagnosis.  
For example, Lucy was reassured by the fact her cancer had not spread to the lymph nodes: 
 
 “But the good news was it wasn’t in my lymph nodes so that was like, em that’s a 
 good thing cause it means it’s not spread, it’s mainly in the one area.” (Lucy) 
 
Sam described finding her experiences of treatment positive, despite her diagnosis: 
 
 “That’s what I mean, from getting really bad news, everything’s quite positive 
 afterwards.  I’m sure it’s not the same experience for everybody, but obviously I’m 
 feeling happy because it’s the best of a bad situation really.” (Sam) 
 
Other women related their positivity to being strong for other people in their lives.  Angela 
commented: 
 
“And it’s something kicks in in your head that – that makes you very positive.  And I 
 had -  I’m on my own with two children […] and I had to stay positive because he 
was going through the middle of all of that [exams].  So my emotions, I was – it was 
as if I was in denial of it.  I’ve not got this, I’ll deal with it, it’s fine.” (Angela) 
 
Angela's description of staying positive suggests that, for her, positivity was a necessity.  
Denial of her own feelings about her diagnosis was necessary for her to stay positive, in 
order to get through treatment.  Some women mentioned denial as strategy that was useful 
to them in the short-term.  For example, Lucy described not wanting to think about 
requiring a wig and then facing up to this: 
 
“So I kind of put off phoning her and then I realised I had to have a wig and 
phoned her and went down.” (Lucy) 
 
Another way in which the women appeared to maintain positivity was through engaging in 
downward comparisons (Willis, 1981) with those they perceived as worse off than 
themselves.  These comparisons were both general and specific.  For example, May stated: 
 
 “There’s always people round about you far worse off.  When you go into the public 
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 domain and talk to other people you realise you’re very lucky.” (May) 
 
For Carol, recalling her sister-in-law's difficult experiences with chemotherapy reassured 
her that her own upcoming radiotherapy might be manageable. 
 
 “My sister in law had breast cancer and she’s okay, and she was worse than what I 
 was.  She got chemo before she got her surgery.  She had quite a hard time of it, but 
 she sailed through it.  So I just kinda look at her and think “well, if she can do it, I 
 can do it.”” (Carol) 
 
 
Staying normal 
 
All the women attempted to maintain some form of normality.  All had returned to work or 
their usual activities following surgery and anticipated that they would continue this during 
their adjuvant treatment.  Sam commented: 
 
“Em, well alright, I’m just obviously trying to work my way through it.  I’ve been 
off work, em, I took two weeks off after the surgery.  Em, but I’m trying to let it not 
 disrupt my work too much.” (Sam) 
 
This also appeared to function as a way of rejecting the cancer patient identity.  Lucy 
described this as such: 
 
 “But for me I just kept going to work and doing all the things I normally do cause I 
 thought, well I’m not going to sit down now and put my head in my hands and think 
 “oh no, I’ve got cancer and that’s it.”  Because if I’m like that at the beginning who 
 knows what state you’ll be in by the time you get to this stage, so I think maybe I’m 
 just a positive person.” (Lucy) 
 
 
Staying present 
 
Three women described coping with their situation by staying in the present.  Carol 
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commented: 
 
“That’s just the way I feel, so just need to take each – each day as it comes.” 
(Carol) 
 
Balancing this with hope for the future was important.  All participants mentioned future 
plans, such as holidays. 
 
 
Family and friends 
 
Although the women interviewed spoke about individual strategies, the influence of family 
and friends on their adjustment was also evident for three of the women.  For some, this 
was a general sense that others were supportive of them: 
 
“It makes you realise how fortunate you are having a sort of loving circle.  A circle 
of friends, an outer circle as well, people I used to work with [...] Ehm, all that is 
great, you know to have people, you know they’re rooting for you.” (May) 
 
The practical help that others offered was also discussed.  One of Lucy's work colleagues 
had established a charity to assist women with cancer during treatment.  The practical and 
emotional aspects of this were important for Lucy: 
 
“She was lovely, she spoke about all her experiences and everything and em we 
 looked through books and different colours and everything […] And it makes you 
feel somebody knows what you’re going through, that’s been through it all and 
knows  what you’re talking about.” (Lucy) 
 
 
Knowing enough 
 
Women described multiple sources of information which impacted their expectations of 
treatment, including healthcare professionals, written information, friends and family, and 
the internet.  Throughout the women's narratives, a process emerged of information 
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unfolding over the course of diagnosis and treatment.  It was important for women to feel 
prepared for the next phase of their treatment.  How much information was enough varied 
between women.  For some women, this did not necessarily entail knowing exactly what 
would happen, but rather knowing that they would find out more in due course.  This is 
illustrated by Lucy: 
 
“I’m not going to know until I have my first appointment here [cancer centre], 
about  the chemo.  Cause the [hospital 2] don’t give you too much.  They tell you 
like, you know, it’s going to be – they told me it would be six rounds of chemo and 
they’re usually three weeks apart […] Em, [pause] but really other than that, that 
was -  I knew I would get more of it,  more information when I came here [cancer 
centre], they’d go more into depth with it and more about different things that you 
might experience, the effects and all that.  But I kinda knew I wouldn’t hear any of 
that.  So although folk were asking me questions, I didn’t know, but I didn’t expect 
to know til I came here because to me this is obviously the specialist place” (Lucy)   
 
This conveys a sense that she was reassured and contained by the healthcare system.  It 
also suggests that information was paced in part by healthcare professionals.  This was 
echoed by Sam, who said: 
 
“But certainly it was, em – probably didn’t explain – go into it in too much detail 
 [surgeon] but I knew that would come with the oncology appointment to be honest 
so, em, when I went to the oncology appointment I got a further leaflet and it was 
 explained in a lot more detail then on the Monday.” (Sam) 
 
The concept of knowing enough was idiosyncratic.  Women did not define what knowing 
enough meant for them in terms of content, but discussed this in terms of their emotional 
reaction to the information.  For all participants, information could both reassure and 
overwhelm.  Carol described how information reduced her fears about treatment:  
 
“Aye well it’s made me – it’s made me aware.  I kinda know better now what my 
sister-in-law went through, but it’s not as scary as what I thought it was.” (Carol)   
 
Information could also be perceived as frightening or overwhelming.  Sam read 
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information about possible life expectancy and found this too difficult to think about: 
 
“Em, because another thing it talks about – your life expectancy after it, which is, 
em, another tool on a website you can use for that.  Still I found that a bit like -  
your life expectancy is maybe ten years and I was like “does that mean I just have 
another ten years to live?”  I found that slightly -  I’m not even going to look at that 
any more, I don’t know.” (Sam) 
 
Participants also emphasised their own agency in ensuring that they knew enough.  May 
read everything she could about her prognosis and treatment.  This seemed to reassure her. 
 
“There’s very, very good websites, eh, online where I’ve read um – You know, the 
 breast awareness website, so – So I’ve read all the, all the – the information there is 
 out there for patients [pause] and I suppose I got a lot from that.  And from that I 
was able to ask “well what stage of cancer have I got?” and, and I was able to look 
at the odds and so on.” (May)   
 
Other participants made decisions about what information to avoid, or when to seek 
information.  Angela stated: 
 
“I’ve deliberately not done it, because the internet can be a scary place if you go 
too deep into it, so I just thought, I’ve found a useful website, that’s what I’ll stick 
to, so I’ve not looked anywhere else.” (Angela) 
 
Interestingly, four women stated that looking at information online could be 
overwhelming, and chose to avoid this, or limit their exposure.  Sam explained her 
decision to digest information in stages, rather than all at once: 
 
“I think you’re just a bit rabbit in the headlights that day anyway, you know, so I 
had a quick kinda sift through it [information pack], but I was just like “no, I’m not 
going to read too much into that.”  Cause I think it can scare you as well sometimes 
if you read all of that, because obviously it’s giving you [...] the worst case 
scenario, so you know, you maybe don’t want it at that stage, to be reading that.  I 
mean, [...] I think it’s more helpful to deal with it at each stage that you’re going 
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through rather than reading it all at once.” (Sam) 
 
Women also had to manage information received from family and friends.  Lucy's 
description captures the dynamic nature of managing the information from others, as well 
as the positive and negative aspects of this: 
 
“At first I was a bit “I don’t really want to speak to people who have experienced 
it” because I thought, well, they tell you a lot of negative stuff and I don’t want the 
 negative, I want the positive.  But there’s two side to it you know, what people tell 
you.   I suppose you really need to open your eyes, this could happen to you, you 
might feel like this. [...] I’ve spoken to a few folk, so I know that it’s – it’s not just 
me, it’s perfectly normal to feel tired, to feel down, to feel a bit not great or 
whatever, that’s a normal experience to have.” (Lucy) 
 
Being able to ask questions about their diagnosis and treatment was discussed by four of 
the women.  They valued the opportunity to ask questions, particularly where they had not 
understood something or felt that shock had prevented them from fully comprehending the 
information.  Two participants emphasised the importance of having enough information in 
order to ask relevant questions.  Angela commented: 
 
“To be prepared, eh, and to give you the opportunity to – to ask questions, because 
 you don’t know what you don’t know when you walk in, and it’s after you walk out 
that you think of questions.” (Angela) 
 
Her quote conveys a sense of being on unfamiliar terrain and needing some information as 
a baseline in order to seek further information.  
 
 
Relationships with healthcare professionals 
 
Women's relationships with the healthcare professionals were a key feature of their 
narratives.  All women spoke positively about their experiences.  They tended to speak in 
general terms about the content of communication from healthcare professionals, and 
focused on their interpersonal qualities.  For example, Angela commented: 
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 “The way I’ve been treated.  The way I’ve been treated.  Em, everybody has been so 
 compassionate with me and very understanding, and – because it is an awful 
 situation.” (Angela) 
 
The words women used to describe their healthcare professionals included “lovely”, 
“approachable” and “understanding.”  This was also evident in the actions of healthcare 
professionals.  Sam described the way in which her nurse answered her questions: 
 
“The nurse had kind of - she had then taken the time to write down all the answers 
on the booklet for me, everything that I was asking, so that I do have it all written 
 down.” (Sam) 
 
Sam's sense that her nurse had gone beyond what she expected of her seemed to help her to 
feel cared for. 
 
Trust in their doctors was important to all the women.  This allowed them to feel confident 
that they were getting the best treatment.  May's description of her surgeon illustrates this: 
 
“And I had eh also eh went online and saw that eh [name of surgeon] had a great 
 reputation – international reputation - eh for her work with research and em she em 
 was a very experienced surgeon [pause].  And I had a breast nurse who I could 
phone  if I had any problems.  So I really felt that I was in a system where they had 
seen all this before and felt very confident.” (May) 
 
Perhaps as a consequence of their perceived trustworthiness, healthcare professionals were 
a valued source of information for all women.  Doctors' communication was important, and 
all women recalled a specific occasion when their doctor or nurse had said something that 
made them feel positive about their prognosis and treatment.  It may be that having 
confidence in healthcare professionals allowed the women to manage the uncertainty 
associated with their treatments. 
 
Women appeared to actively make sense of professionals' communications.  For example, 
Lucy interpreted her surgeon's matter-of-fact communication style as being a sign that her 
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prognosis was good. 
 
Lucy: “Dr [breast surgeon], who was the lead over there for the breast surgery, she 
 just tells you it as it is [laughs].  She said “there’s cancer here, here, here and 
here”.   I suppose, probably she’s saying it all day every day, to everybody.  I’m not 
saying she wasn’t pleasant, but she was very, em [pause]” 
 
 Interviewer:  “She sounds very matter of fact.” 
 
Lucy:  “Uh-huh! [laughs]  That’s it exactly.  Well, I think sometimes, for me, it was 
– I – I could maybe cope with that better.  I think it’s when people start to be kinda 
too – too nice to you that it makes you feel, you know, that there’s really, there’s 
really,  something really bad wrong with you.  And when people are more matter of 
fact it makes you think, you know, people are going through this all the time, it 
happens to loads of people.” (Lucy) 
 
Women viewed the role of their doctors and breast care nurses differently.  This was both 
explicit and implicit in their narratives.  Doctors were seen as being in charge of women's 
overall care, as well as providing information about treatment and its side effects.  Nurses 
appeared to have a role in clarifying and expanding on information provided by the doctor.  
May commented:  
 
 “I also was introduced to the breast nurse and I thought it was quite clever the way 
 she, em, said “Right tell me now what [pause] you’ve been told by the oncologist so 
 that I’m not repeating myself.” [...] I realise this is a clever way of finding out if 
 you’ve remembered anything! [laughs]” (May) 
 
For some women, the role of the nurse was also tied closely to the provision of practical 
and emotional support.  Angela stated: 
 
“Do you know, and I found this quite funny, if you are talking to the oncologist or 
the surgeon or whatever, she wasn’t in the room then all of the sudden she was in 
the room. What’s it got to - it's as if she jumped out of a cupboard or a filing cabinet 
or something, it's like just she just appeared from, em – […] they just seem to be 
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there by your side.” (Angela) 
 
Angela's experience conveys a sense that her needs were anticipated before she was fully 
aware of them.  Nurses also seemed to provide a sense of continuity for the women, as they 
had contact with one or two nurses over the course of their treatment.  Four of the women 
spoke about the importance of knowing who was there if they had questions or needed to 
speak to someone.  For all women, this was their breast care nurse.  Sam commented: 
 
“Yeah, I mean certainly, it was reassuring to know that there is someone there on 
the end of a phone that you can call when you do have questions.  Cause, you know, 
 hospitals are big places so you wouldn’t know how to start to get hold of people to 
get questions answered.  So yeah, no, I find that very helpful.” (Sam) 
 
 
Discussion 
 
This study explored the experiences of women in the time period between surgery and 
adjuvant treatment for breast cancer.  This time was characterised by anxiety and 
uncertainty about adjuvant treatment.  Women expected that further treatment might be 
unpleasant.  Their efforts to manage uncertainty at this time point took place in the wider 
context of their adjustment to the diagnosis of cancer.  Coping was supported by 
relationships with healthcare providers and the information they received. 
 
Women in the present study had to cope with the uncertainty associated with adjuvant 
treatment.  They had experienced a disruption to their normal lives through surgical 
treatment and attempted to regain normality by returning to their usual activities.  Adjuvant 
treatment seemed to represent a further threat to normality, both in terms of disruption of 
daily life routines and potential side effects.  Women anticipated disruption, but 
experienced uncertainty about the nature of this disruption.  Previous research has 
demonstrated that people experience uncertainty throughout the cancer journey.  Waiting 
for treatment may be a particularly uncertain time.  Drageset, Lindstrom, Giske & Underlid 
(2010) interviewed women with breast cancer prior to surgery.  Women experienced high 
levels of uncertainty related to their treatment and prognosis.  A review (Shaha, Cox, 
Talman & Kelly, 2008) found that uncertainty in cancer care related to three main areas: 
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uncertainty regarding treatment and prognosis, uncertainty about coping, and uncertainty 
related to insufficient information.   
 
Uncertainty in illness theory (Mishel, 1990) proposes that uncertainty is the difficulty in 
ascribing meaning to illness related events.  Two factors are hypothesised to influence 
individuals’ experience of uncertainty – cognitive capacity and resources available to help 
them make sense of the experience.  Resources include education, social support and 
credible authority.  Individuals then appraise the meaning of their experienced uncertainty.  
Uncertainty can be evaluated as a threat or as an opportunity.  Women in the present study 
seemed to engage in a process of preparing for side effects whilst downplaying the 
possibility of experiencing these.  Uncertainty may be adaptive for women at this point in 
time, as it could represent an opportunity to maintain hope and optimism in the face of 
potentially unpleasant treatments.   
 
Perhaps unsurprisingly, given the time scales involved, women continued to adjust to their 
diagnosis.  Stress and coping theory offers a way to understand women's experiences at 
this point (Lazarus & Folkman, 1984).  It delineates two broad types of coping strategies 
that people use in response to a threatening event, such as illness.  Problem-focused coping 
strategies include efforts to manage cause of the stress.  Emotion-focused coping strategies 
are directed toward reducing emotional distress.  Emotion-focused coping is more 
commonly used when events are perceived as less controllable (Lazarus & Folkman, 
1984).  Women in this study seemed to use a mix of emotion-focused and problem-focused 
coping strategies.  These included: attempting to stay positive, maintaining normality, 
staying in the present, and utilising support from family and friends.  Given that women 
are unable to predict what side-effects they will experience and what they may be able to 
control, this mix of coping strategies might be expected.   
 
The present research suggests the women wanted to know enough about their treatment to 
reduce uncertainty, but did not wish to overwhelm themselves with information that was 
fear-inducing.  Information appeared to unfold over the course of diagnosis and treatment, 
as women negotiated the healthcare environment.  Women engaged in a process of 
controlling information in order to meet their individual needs, which were highly 
idiosyncratic.  Research increasingly demonstrates that information needs in cancer care 
are dynamic and change over time, as a function a number of factors, including the stage of 
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treatment, the individual's personal circumstances and interactions with others (Rutten et 
al., 2005).  The results of this study show that women actively manage the information 
they receive.  This is important, as early research did not consider how women actively 
shape and manage information.   
 
Recent studies lend support to this interpretation.  Furber, Bonas, Murtagh and Thomas 
(2015) analysed interviews with five people with cancer following their first oncology 
appointment, using IPA.  They reported a dynamic interplay between the need for 
information and the desire to avoid certain bits of information.  Similarly, a meta-
ethnography of qualitative studies examining information-seeking in people with cancer 
found that seeking information and avoiding information may not be separate behaviours, 
but rather part of a dynamic process of controlling information in order to meet individual 
needs (Germeni & Schulz, 2014).  They suggest five factors which prompt people to seek 
or avoid information: the shock of diagnosis, the desire for control, trust in healthcare 
professionals, a desire to maintain hope, and the need to return to normality.  Avoiding or 
seeking information can fulfil each of these goals. 
 
Healthcare professionals were a valuable source of information for participants.  The 
interpersonal aspects of professionals' communication were as important as the information 
they shared.  Trust in professionals was important to participants.  Feeling that 
professionals are in control of the illness perhaps allows individuals to feel more in control 
themselves (Walker, Jackson & Littlejohn, 2004).  This could support women's attempts to 
cope.  Information-giving might allow women to develop trust in their doctors, which in 
turn facilitates the sharing of information (McWilliam, Brown & Stewart, 2000).  
According to uncertainty in illness theory (Mishel, 1990), healthcare professionals 
represent a source of credible authority – that is, they can support the management of 
uncertainty by providing information about the illness and treatment.  The important role 
of nurses in providing practical and social support, as well as a sense of continuity, fits 
with findings from previous research (Liebert & Furber, 2004).   
 
 
Limitations 
 
In line with IPA a homogeneous sample was recruited, consisting of women with early-
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stage breast cancer undergoing specific treatments.  Therefore, the results may not be 
applicable to women with metastatic breast cancer, where concerns are likely to be 
different, or to women receiving different treatment combinations, such as chemotherapy 
before surgery.  In addition, women who had already agreed to their adjuvant treatment 
plan took part in this study.  It should also be noted that four of the five participants said 
they had been accurately prepared for further treatment by their surgeon.  This does not 
capture the experiences of women who were undecided about adjuvant treatment, those 
who did not wish to pursue further treatment, and those who received a treatment different 
from that which they anticipated.  Interviewing women post-surgery but prior to 
confirmation of their adjuvant treatment may have captured this uncertainty, but it was 
identified that asking women about expectations of further treatment when this had not 
been confirmed would be ethically problematic.  Nonetheless, the themes of the present 
study and earlier research (Shaha et al., 2008) suggest that uncertainty pervades across the 
cancer trajectory.  It may be that the content of women’s worries changes at different 
stages. 
 
Recruitment of participants was difficult.  There may be a number of reasons for this.  
Women receive a great deal of information about treatment at the first oncology 
appointment, particularly those who will be having chemotherapy.  They may also be asked 
to enter clinical trials at this point.  Women perhaps feel overwhelmed by the volume of 
information they receive at this time.  In addition, women's distress levels might be higher 
at this time.  Participants in this study emphasised their attempts to maintain a positive 
outlook.  It may be that these women represent a sub-group who cope particularly well and 
therefore felt more able to discuss their experiences.  The manner of recruitment to the 
study may also be a source of bias.  Potential participants were selected by their breast care 
nurses.  It may be that nursing staff chose women experiencing less distress, those who 
were satisfied with the service they had received so far, or those who seemed more able to 
articulate their experiences.  Therefore, participants in this study may not represent the full 
range of experience in terms of care received.  Future research could consider different 
recruitment strategies that may reduce this source of bias – for example, the use of posters.   
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Future Directions and Implications 
 
Although they were interviewed at one time point in their treatment, all women described a 
dynamic process of information unfolding and changing.  Further research could take a 
longitudinal perspective by interviewing women at different points during diagnosis and 
treatment, to capture their experiences at each stage.  The experiences and needs of women 
with different treatment pathways could also be examined. 
 
Although all the women interviewed experienced worry about their adjuvant treatment, 
there was evidence of some differences between radiotherapy and chemotherapy.  These 
related largely to the anticipate side effects.  For example, women about to undergo 
chemotherapy discussed concerns about hair loss, nausea and vomiting and other 
unpleasant potential side-effects, whereas women awaiting radiotherapy discussed 
concerns related to fatigue and being burned.  All participants anticipated that treatment 
and possible side effects would be disruptive to their daily lives.  This suggests the 
importance of ascertaining women’s specific concerns about treatment and how these 
relate to their own lives and situations.  Further exploration of treatment-specific concerns 
and comparison of differences is warranted. 
 
This study adds to a growing body of literature demonstrating that information needs are 
complex and dynamic.  Communication with healthcare professionals is vital.  
Interpersonal qualities and human connection are as important as information giving.  This 
suggests that the focus should be on supporting women to articulate their particular needs 
at different times in different situations, and on supporting healthcare professionals to 
respond flexibly.   
 
 
Conclusion  
 
The results of this study suggest that the period between surgery and adjuvant treatment is 
characterised by uncertainty.  Women's efforts to manage this uncertainty are important, as 
is the information and support they receive from healthcare professionals.  Information 
needs are met in an interpersonal context, in which women feel cared for and supported.  
Healthcare professionals should respond flexibly to women's information needs. 
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Chapter 3: Advanced Clinical Practice I – Critical Reflective Account 
 
Formulation: getting it right? 
 
 
 
 
 
Abstract 
 
Formulation is one of the key competencies of clinical psychologists (Division of Clinical 
Psychology, 2010).  In this account I reflect on my experiences of formulation over the 
course of training, and how my ideas and feelings have changed.  In particular, I focus on 
my concerns about needing to do formulations the “right” way and how this has changed 
over the course of training. Johns' (2004) Model of Structured Reflection is used to 
structure reflections on specific experiences and the Integrated Developmental Model 
(IDM; Stoltenberg & McNeill, 1997) is used to think about my experiences in the context 
of my overall development as a clinical psychologist.  Finally, I reflect on the experience 
of writing the account and the impact of the wider context in which we practice.  Future 
directions for developing my skills in formulation are also discussed.   
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Chapter 4: Advanced Clinical Practice II – Critical Reflective Account 
 
A reflection on my experiences of delivering teaching and training to others 
 
 
 
 
 
Abstract 
 
Clinical psychologists are increasingly expected to share psychological knowledge and 
skills with others (The Scottish Government, 2011).  One way in which this is done is 
teaching and training of other staff.  In this account I reflect on two experiences of 
delivering teaching to others.  The first experience, in second year, was one that did not go 
so well and the second experience, in third year, was one that seemed to be better.  Rolfe, 
Freshwater and Jasper's (2001) framework for reflective practice is used to structure my 
reflections, by considering the questions “what?” “so what?” and “now what?” in relation 
to these experiences.  Reference is also made to the Integrated Developmental Model 
(IDM; Stoltenberg & McNeill, 1997) to set these experiences in the context of my 
development as a clinical psychologist.  In this account I discuss my concerns about 
delivering teaching and training and how my feelings vary depending on context.   Finally, 
areas for future learning and professional development are considered. 
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contextualized by 
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review, location of literature to contextualize 
the findings, or both  
 
Design 
 
Method/design 
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research intent 
 Rationale given for use of qualitative design  
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 Evidence that the subjective meanings of 
participants were portrayed  
 Evidence of more than one researcher involved 
in stages if appropriate to 
epistemological/theoretical stance  
 Did research participants have any 
involvement in analysis (e.g. member 
checking)  
 Evidence provided that data reached saturation 
or discussion/rationale if it did not  
 Evidence that deviant data was sought, or 
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Interpretation 
 
Context described 
and taken account 
of in interpretation 
 
 Description of social/physical and 
interpersonal contexts of data collection  
 Evidence that researcher spent time ‘dwelling 
with the data’, interrogating it for 
competing/alternative explanations of 
phenomena  
 
 Clear audit trail 
given 
 
 Sufficient discussion of research processes 
such that others can follow ‘decision trail’  
 
 Data used to 
support 
interpretation 
 
 Extensive use of field notes entries/verbatim 
interview quotes in discussion of findings  
 Clear exposition of how interpretation led to 
conclusions  
 
Reflexivity Researcher 
reflexivity 
demonstrated 
 Discussion of relationship between researcher 
and participants during fieldwork  
 Demonstration of researcher’s influence on 
stages of research process  
 Evidence of self-awareness/insight  
 Documentation of effects of the research on 
researcher  
 Evidence of how problems/complications met 
were dealt with  
 
Ethical 
Dimensions 
Demonstration of 
sensitivity to 
ethical concerns 
 
 Ethical committee approval granted  
 Clear commitment to integrity, honesty, 
transparency, equality and mutual respect in 
relationships with participants  
 Evidence of fair dealing with all research 
participants  
 Recording of dilemmas met and how resolved 
in relation to ethical issues  
 Documentation of how autonomy, consent, 
confidentiality, anonymity were managed  
 
Relevance 
and 
transferability 
 
Relevance and 
transferability 
evident 
 
 Sufficient evidence for typicality specificity to 
be assessed  
 Analysis interwoven with existing theories and 
other relevant explanatory literature drawn 
from similar settings and studies  
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 Discussion of how explanatory 
propositions/emergent theory may fit other 
contexts  
 Limitations/weaknesses of study clearly 
outlined  
 Clearly resonates with other knowledge and 
experience  
 Results/conclusions obviously supported by 
evidence  
 Interpretation plausible and ‘makes sense’  
 Provides new insights and increases 
understanding  
 Significance for current policy and practice 
outlined  
 Assessment of value/empowerment for 
participants  
 Outlines further directions for investigation  
 Comment on whether aims/purposes of 
research were achieved 
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Appendix 3: Summary of themes as expressed in each study  
(NB: X indicates theme not expressed in study) 
 
 
 
 
Themes from meta-ethnography 
Women’s role in decision 
making 
Emotional impact of 
breast cancer 
 
Patient-doctor 
relationship 
Managing information Family and friends 
Charles et 
al. (1998) 
- Some women wanted the 
doctor to make the 
decision 
- Some wanted shared 
decision-making 
- Some wanted final say 
- Decision-making as a 
dilemma for women 
- Doing nothing is not an 
option – women feel a 
need to do everything they 
can to fight cancer 
- Maintaining hope and 
positivity 
- Some women see doctor 
as expert who should make 
the decision 
- Some wanted doctors’ 
advice to enable own 
decision 
- Weighing up benefits and 
risks of treatment 
- Developing an 
idiosyncratic 
understanding of 
information 
- Transforming risk data 
into personally meaningful 
categories 
X 
Lam et al. 
(2005) 
- Women felt responsible 
for decision-making 
- Experienced uncertainty 
and indecisiveness 
 
- Some form of treatment 
is the only choice 
- Emotional response to 
cancer – fear, uncertainty 
- Perceived seriousness of 
cancer 
- Survival is highest 
priority – choices are 
driven by fear of death / 
recurrence 
- Uncertainty about 
decision 
- Identifying surgeons’ 
preferences 
- Women trust surgeons’ 
knowledge and expertise 
- Wanting doctors to 
choose for them 
- Difficulty assimilating 
information due to fear 
- Prioritising personal aims 
– weighing information 
based on factors relevant 
to individual 
- Seeking and evaluating 
information from a range 
of formal and informal 
sources 
- Seeking and avoiding 
information as a means to 
cope 
- Prioritising personal aims 
– preserving relationships 
with significant others and 
minimising life disruption 
- Seeking opinions of 
family 
Halkett et - Women make many - Survival – decisions are - Establishing relationships - Getting ready – - Sharing the challenge – 
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al. (2007) decisions; not all are overt 
and all impact on the 
others 
- Lack of control over 
decisions – trusting doctor 
to make decision 
- Regaining control 
afterwards 
characterised by a need to 
survive 
- Cancer as a challenge to 
existence and sense of self 
– threat of death 
- Interrogating the future – 
wondering about 
recurrence  
with doctors 
- Putting trust in medical 
practitioners 
- Support from medical 
practitioners  
developing understanding 
through information and 
discussion with others 
family and friend can 
actively support women 
- Support and reassurance 
- Choosing who to involve 
- Some actively involved 
in decisions but some need 
own support 
Husain et 
al. (2008) 
- Reliance on medical 
professionals to make a 
decision 
- Doing what the doctor 
thinks is best 
- Diagnosis of cancer – 
worry about fear of 
metastases and recurrence 
- Relying on healthcare 
professionals to decide 
- Doing what the doctor 
says 
- Listening for clues to 
doctors’ treatment 
preferences 
- Women did not ask 
questions or seek 
treatment information – 
reliance on healthcare 
professionals to tell them 
X 
O'Brien et 
al. (2008) 
- Some women surprised 
to be offered a choice 
- Some identified a 
preferred treatment pre-
consultation 
- Some women wanted the 
doctor to decide 
- Women wanted a 
treatment that would give 
them the best chance of 
survival 
- Some women want the 
doctor to decide 
- Doctors’ 
recommendations are 
valued – gave women 
confidence in their own 
decisions 
- Trying to infer doctors’ 
preferences where these 
are not explicit 
- Seeking information 
about options pre-
consultation (formal and 
informal sources) 
- Using information to 
make a decision – 
idiosyncratic 
understanding 
- Some women did not get 
as much information as 
they wanted from doctors 
- Seeking information 
from others about 
treatment options – social 
network 
- Considered options with 
family and support 
network 
Lally 
(2009) 
- Some women had strong 
treatment preferences pre-
consultation, but did not 
tend to share these 
- Choices motivated by 
desire to eliminate future 
inconvenience and worry 
about cancer 
- Interacting with doctors  
- Surgeon instils trust and 
feeling of being cared for 
- Wanting a 
- Managing amount of 
information – information 
could be overwhelming 
- Formal and informal 
- Informal sources of 
information, such as 
friends, used 
- Interacting with others – 
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- Women tended to make 
their own choices based on 
interactions with medical 
professionals 
- Informed decision-
making 
- Some women worried 
about having made the 
right decision 
recommendation from 
doctors 
- Taking confidence from 
doctors’ support of 
decisions 
sources used 
- Information can help 
women avoid surprise 
- Some women avoided 
information and some 
approached it 
- Information, perceived 
knowledge and beliefs 
drove preferences 
knowledge of other 
women’s experiences 
- Family and friends 
provide reassurance and 
support for decisions 
- Deciding who to involve 
Caldon et 
al. (2011) 
- Variation in decision-
making roles between 
women 
- Some women surprised 
to be offered choice 
- Most women wanted a 
role in decision-making 
- Some women acquiesced 
to doctor 
- Most reassuring option 
chosen to reduce anxiety 
about recurrence 
- Vacillation between fear 
of recurrence and body 
image concerns 
- The shock of diagnosis 
- Doctors are primary 
information providers 
- Surgeons’ framing of 
choices influences 
decision 
- Doctor perceived as 
powerful – some women 
acquiesce  
- Style and content of 
information is important 
- Context is important – 
the earlier women were 
told about making a 
decision, the more they 
seemed to choose 
mastectomy 
- Choosing the least 
disruptive treatment option 
in terms of wider life 
commitments  
- Impact of surgery on 
sexual relationships 
Pieters et 
al. (2012) 
- Women made their own 
decisions – self-reliance; 
confidence 
- Making the best 
decisions for their 
circumstances – unique to 
each woman 
 
- Impact of diagnosis – 
shock and uncertainty 
- Needing to make 
decisions quickly – feeling 
unprepared 
- Asking clinicians 
questions to create a 
conversation 
- Interpreting healthcare 
providers – reading their 
dispositions 
- Determining 
trustworthiness 
- Obtaining information 
from formal and informal 
sources.  Creates 
conversations with doctors 
- Emotional appraisals 
more important than facts 
- Women actively seek 
information, but too much 
information unhelpful and 
overwhelming 
- Mutual caring for self 
and others – deciding who 
to take to appointments 
- Making some decisions 
based on wider 
responsibilities 
- Asking family and 
friends for information 
O'Brien et 
al. (2013) 
- Variety in level of 
decision-making 
 
X 
 
X 
- Women used formal and 
informal sources to gather 
- Family and friends can 
be a source of information 
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involvement 
- Most women involved in 
final decision 
- Decisions happen in and 
out with medical 
appointments 
- Deliberating about 
options 
- Some women had a 
strong preference 
beforehand 
information 
- Information can be 
overwhelming 
- It can be difficult to 
understand some 
information 
- Family and friends are 
sometimes involved in 
making the decision 
Weber et 
al. (2013) 
- A variety of decision-
making styles were 
identified 
- Medical expert – doctor 
makes decision 
- Self-efficacy – women 
make decision 
- Relationship embedded - 
ensuring survival to spend 
more time with family 
- Inhibition – wanting to 
avoid negative outcome 
- Constellation of 
information – using 
information from various 
sources 
- Inhibition style of 
decision-making based on 
fear – wanting to avoid a 
negative outcome (e.g. 
pain, death) 
- Following the doctor’s 
advice – doctor is the 
expert 
- Trust in the doctor 
- Women were on a 
continuum of low to high 
information needs 
- All women used 
information fluidly – 
sometimes approaching it 
and sometimes avoiding it 
- Relationship embedded 
style of decision-making; 
ensuring survival to spend 
more time with family 
- Influence of significant 
others evident in all 
decision-making styles to 
some degree 
- Continuum of other- to 
self-focus 
Covelli et 
al. (2015) 
- Taking control of cancer 
– the final decision was 
made by women alone, 
- Shock and fear of 
diagnosis 
- Understanding of 
- Doctors as a source of 
information 
- Subjective risk 
perception outweighs the 
facts 
-Personal experiences of 
family and friends 
heighten fear 
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although others were a 
source of support 
recurrence and survival – 
fear of cancer returning 
- Mastectomy eliminates 
risk and means survival – 
fear and anxiety related to 
recurrence 
- Fear underpins 
information use  
- Emotional information 
most salient 
- Family and friends 
provide support for 
decisions but women make 
decisions alone 
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Appendix 4: West of Scotland Research Ethics Approval 
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Appendix 5: NHS Greater Glasgow and Clyde Research and Development 
Management Approval 
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Appendix 6: West of Scotland Research Ethics Approval Amendment
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Appendix 7: NHS Greater Glasgow and Clyde Research and Development 
Management Approval - Amendment 
 
Dear Miss McAllister 
 
R&D Ref: GN14ON466 
Ethics Ref: 14/WS/1103 
Investigator :Dr Sarah Wilson 
Project Title: A qualitative investigation of the experiences of women with breast cancer between surgery and 
adjuvant chemotherapy. 
Protocol Number:V9 dated 16/03/15 
Amendment: SA01 dated 16/03/15 
Sponsor: NHS GG&C Health Board 
 
I am pleased to inform you that R&D have reviewed the above study.  Amendment and can confirm that 
Management Approval is still valid for this study. 
 
Reviewed Documents:  Version Dated 
Sponsor authorisation email --- 16/03/15 
Notification of Amendment form 3.5 16/03/15 
REC approval --- 27/03/15 
Interview schedule  3.0 16/03/15 
Letter to clinicians  3.0 16/03/15 
Letter to participants  3.0 16/03/15 
Participants consent sheet  4.0 16/03/15 
PIS  4.0 16/03/15 
Protocol  9.0 16/03/15 
 
I wish you every success with this research project. 
 
Yours sincerely 
Lorraine 
 
Lorraine Reid 
Senior Research Administrator 
Research & Development 
R&D Management Office 
1st Floor, Tennent Institute 
Western Infirmary 
Glasgow 
G11 6NT 
Tel: 0141 211 1743 
  
 
102 
 
Appendix 8: NHS Greater Glasgow and Clyde Research and Development 
Management Approval – Amendment 
 
 
Dear Miss McAllister, 
  
R&D Ref: GN14ON466  
Ethics Ref: 14/WS/1103 
Investigator: Dr Sarah Wilson 
Project Title: A qualitative investigation of the experiences of women with breast cancer between 
surgery and adjuvant chemotherapy. 
Protocol Number: V9 dated 16/03/15 
Amendment: NSA (AM02) dated 19/05/15 
Sponsor: NHS GG&C Health Board 
 
I am pleased to inform you that R&D have reviewed the above study Amendment and can confirm 
that Management Approval is still valid for this study.  
 
 
Reviewed 
Documents:                                                            
 Version 
 
Dated 
PIS (RAH) Clean &TC V4 16/03/15 
PIS (VoL) Clean &TC V4 16/03/15 
SSI Form (RAH) V4.0 22/05/15 
SSI Form (VoL) V4.0 22/05/15 
Head of Department Approval Email --- 29/05/15 
 
 
Kind Regards, 
 
Research and Development Department 
NHS Greater Glasgow and Clyde 
Research and Development Central Office 
Tennent Institute 1st Floor 
Western Infirmary 
38 Church Street 
Glasgow, G11 6NT 
Scotland, UK 
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Appendix 9: Participant Consent Form 
 
        
  
 
 
Consent Form 
 
Title of study:  A qualitative investigation of the experiences of women with breast cancer 
between surgery and adjuvant therapy 
 
Name of researcher:  Lauren McAllister 
 
Contact details:  Academic Department,  
       First Floor, Admin Building, 
        Gartnavel Royal Hospital, 
       1055 Great Western Road 
       Glasgow, G12 0XH 
       Email: l.mcallister.1@research.gla.ac.uk  
 
Please write your initial in each box if you agree with the statement: 
 
1. I confirm that I have read and understand the information sheet    
(version 4, 16/03/15) for the above study       
    
2. I confirm that I have had the chance to consider the information    
and that the researcher has answered any questions to my satisfaction 
 
3. I understand that my participation is voluntary and that I am free to    
 withdraw from the study at any point without having to give a reason   
and with no consequences 
 
4. I understand that I can ask for my data to be withdrawn from the    
research at any point 
 
5. I understand that my information will remain confidential and that any  
  
information that could identify me will not be made publicly available.     
Representatives from NHS GG&C may look at my information for  
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audit purposes 
 
6. I give permission for my interview with the researcher to be    
digitally recorded 
 
7. I give permission for anonymised quotations from my interview to be    
used in reports about the research                     
                                                                         
8. I give permission for the Consultant Oncologist in charge of my     
overall care to be informed of my participation in this study   
   
9. I consent to being a participant in this project     
           
   
_______________________     _____________      _______________________ 
Name of participant      Date        Signature 
 
 
_____________________     _____________      _______________________ 
Researcher         Date        Signature 
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Appendix 10: Participant Invitation Letter 
 
          
  
 
Dear 
 
A qualitative investigation of the experiences of women with breast cancer between 
surgery and adjuvant therapy 
 
My name is Lauren McAllister and I am a Trainee Clinical Psychologist studying at the 
University of Glasgow.  As part of my training, I am carrying out a research study looking 
at the experiences of women with breast cancer in the period between surgery and adjuvant 
treatment.  Adjuvant therapy is treatment that you have after surgery.  This could be 
radiotherapy or chemotherapy.  I enclose an information sheet for you to read over. 
 
If you decide that you would like to take part in the study, I will contact you to arrange a 
time for an interview. This interview could take place in the Beatson West of Scotland 
Cancer Centre, or over the telephone if you would prefer. Either option would involve a 
discussion of up to 60 minutes to find out about your experiences.  
 
The discussion will be recorded on a digital voice recorder to ensure that I gain a full 
understanding of your views.  All information will be treated with the utmost 
confidentiality, however, if something is revealed during the discussion that suggests you 
or anyone else is at risk of harm, you will understand that it is then my duty to share this 
information with other appropriate health professionals.  You will be able to take breaks 
during the interview at any time you wish for any reason.  After recording, the interview 
will be transcribed word for word and any references to people or places will be made 
anonymous. Once the transcript has been checked for completeness and accuracy, the 
recording will then be destroyed. It will not be possible to identify you from the transcript 
as it will be given a code for identification. Information linking your name to the 
identifying code will be stored separately and securely from the rest of the data. 
 
If you would like more information, please do not hesitate to contact me by telephone on 
07979 495942 or by email at l.mcallister.1@research.gla.ac.uk.  
 
Yours sincerely, 
 
Lauren McAllister 
Trainee Clinical Psychologist 
 
Supervised by: 
 
Dr Sarah Wilson                 Dr Christopher Hewitt 
Senior Lecturer in Health Psychology                    Consultant Clinical Psychologist 
University of Glasgow          Beatson West of Scotland Cancer Centre 
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Appendix 11: Participant Information Sheet 
 
         
  
 
 
Participant Information Sheet 
 
Introduction   
My name is Lauren McAllister, and I am a Trainee Clinical Psychologist enrolled at the 
University of Glasgow.  You have been given this information sheet because you are being 
invited to take part in my final-year research project, which will be submitted as part of my 
Doctorate in Clinical Psychology.  The project is supervised by Dr Sarah Wilson, Senior 
Lecturer in Health Psychology, School of Medicine, University of Glasgow and Dr 
Christopher Hewitt, Consultant Clinical Psychologist. 
 
Title of study   
A qualitative investigation of the experiences of women with breast cancer between 
surgery and adjuvant therapy 
 
What is the purpose of the study? 
I am interested in finding out about your experiences of the time between receiving surgery 
for breast cancer and starting adjuvant therapy.  Adjuvant therapy is treatment that you 
have after surgery.  This could be chemotherapy or radiotherapy.  In particular, I am 
interested in your experiences of communicating with the different healthcare professionals 
involved in your treatment so far, and how these experiences have impacted on your 
expectations of your treatment. 
 
Why have I been chosen as a potential participant? 
You have been given this information sheet because you have recently had treatment 
surgery for breast cancer and are scheduled to undergo adjuvant therapy as part of your 
treatment. 
 
Do I have to take part?   
No.  You do not have to take part in this study if you do not wish to.  Participation in the 
study is entirely voluntary.  Your care and treatment will not be affected in any way if you 
choose not to take part in the study.  You are also free to withdraw from participation in the 
study at any point.  You do not have to give a reason if you decide to withdraw from the 
study.  You may also request that any information you have provided is withdrawn from 
the study. 
 
What will happen if I choose to take part? 
If you decide you would like to take part in the study, I will contact you to arrange a 
suitable time to meet with you.  We will meet in a private room at the Beatson West of 
Scotland Cancer Centre.  I will ask you to sign a consent form (Version 4, 16/03/2015) to 
confirm that you understand what is being asked of you and that you are happy to take part.  
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The interview will last for no more than one hour.  I will electronically record the interview 
to make sure that I have an accurate record of what we have talked about. 
 
Alternatively, if you decide you would prefer a telephone interview I will post a consent 
form (Version 4, 16/03/2015) to you before the interview, with a stamped addressed 
envelope for you to return the form.  Once I have received your completed consent form, I 
will contact you to arrange a suitable time for the interview. The call to you will be made 
from a private room.  The interview will last no more than one hour.  Telephone interviews 
will also be recorded using a digital voice recorder to ensure an accurate record of what is 
discussed.   
 
Are there any risks or disadvantages to taking part in the study? 
There are no direct risks involved in taking part in this study, although you might find it 
distressing speaking about some of your experiences.  You may take a break or stop the 
interview at any point if you choose to do so.  If you need further support after the 
interview, arrangements can be made for this. 
 
Are there any benefits of taking part in the study? 
There are no direct benefits to you of taking part in this study; the findings from this study 
may lead to new knowledge, which could be used to help other people in a similar situation 
to you in the future. 
 
Will my information remain confidential? 
Any information you provide as part of the study will remain confidential.  The only 
people who will have access to this information will be the lead investigator, the academic 
supervisor (Dr Sarah Wilson) and the field supervisor (Dr Christopher Hewitt).  
Representatives of the study Sponsor, NHS GG&C may also have access to your 
information to make sure the study is being conducted properly.  Your information will be 
stored securely.  The Consultant Oncologist in charge of your overall care will know that 
you are taking part in the study.  They will not be told what you have said in the interview 
unless I have to break confidentiality if there was anything discussed in your interview that 
suggested there was a risk to yourself or to someone else.  I would discuss this with you 
first. 
 
What will happen to my information? 
The results of the study will be written up as a report, which will be submitted as part of 
the lead researcher's Doctorate in Clinical Psychology.  The results will also be submitted 
for publication in a scientific journal and may be presented at conferences.  Quotes may be 
used from what you have said in the reports.  However, any information that could identify 
you, such as your name or location, will be removed from any reports.  You will also have 
the option to be notified when the study report is available. 
 
Following your interview, the recording will be kept in a locked cabinet.  Only the 
researchers will be able to access this.  After the interview has been transcribed it will be 
deleted from the recording device and computers.  Transcriptions will be stored on a secure 
password protected laptop. 
 
Who has reviewed the study? 
A member of the course team from the West of Scotland Doctorate in Clinical Psychology 
programme has reviewed the study.  Approval has also been given by the West of Scotland 
Research Ethics Committee and NHS Greater Glasgow and Clyde Research & 
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Development department. 
 
What to do next 
If you have any further questions about the study or would like to discuss it further, please 
do not hesitate to email me on l.mcallister.1@research.gla.ac.uk or telephone me on 07979 
495942.  If you wish to find out more about taking part in research you can visit the 
INVOLVE website at http://www.invo.org.uk/ .  This is an independent website. 
 
If you would prefer to discuss the project with a person who knows about, but is not 
directly involved in this research please contact Dr. Alison Jackson on 0141 211 0607. 
 
If you decide that you would like to take part, please complete the opt-in form below and 
return it in the stamped addressed envelope provided.  Once I have received this I will 
contact you to arrange a suitable time to meet with you.  You have up to three days from 
receiving this information sheet to opt-in.  This is because interviews will be carried out 
before your chemotherapy starts. 
 
If you do not wish to take part you do not need to do anything else.   
 
I would like to thank you for taking the time to read this information sheet. 
 
 
Contact Details 
 
Principal Investigator 
 
Lauren McAllister 
Trainee Clinical Psychologist 
Mental Health & Wellbeing, 
First Floor, Admin Building, 
Gartnavel Royal Hospital, 
1055 Great Western Road 
Glasgow, 
G12 0XH 
 
 
Academic Supervisor 
 
Dr Sarah L. Wilson 
Senior Lecturer in Health Psychology,  
Mental Health & Wellbeing, 
First Floor, Admin Building, 
Gartnavel Royal Hospital, 
1055 Great Western Road 
Glasgow, 
G12 0XH 
 
 
Field Supervisor  
Dr Christopher Hewitt 
  
 
109 
 
Consultant Clinical Psychologist 
Beatson West of Scotland Cancer Centre, 
1053 Great Western Road, 
Glasgow, 
G12 0YN 
_  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  
 
Research study: A qualitative investigation of the experiences of women with breast 
cancer between surgery and adjuvant therapy 
 
Researcher:  Lauren McAllister, Trainee Clinical Psychologist 
 
I am interested in taking part in this study. 
 
My preferred means of contact is*:  post / telephone / email  * delete as 
appropriate 
 
Please provide details of your preferred means of contact in the space below 
 
 
Address:  _________________________________________________________ 
 
               __________________________________________________________ 
 
    __________________________________________________________ 
 
 
Telephone number:  ________________________________________________ 
 
 
Email address:  __________________________________________________   
 
 
If you wish to be contacted by telephone, are you happy for a message to be left on an 
answering machine?   Yes / No *  *delete as appropriate 
 
Participant name:       Date: 
 
Signature: 
 
 
Return Address:  
 
Lauren McAllister 
Trainee Clinical Psychologist 
Mental Health & Wellbeing, 
First Floor, Admin Building, 
Gartnavel Royal Hospital, 
1055 Great Western Road 
Glasgow, 
G12 0XH 
  
 
110 
 
Appendix 12: Interview Schedule 
 
      
  
 
 
Interview Schedule 
 
Introduction 
 introduce myself and my role as researcher / trainee clinical psychologist 
 thank participant for agreeing to take part in the study 
 remind participant about confidentiality and its limits 
 remind participant that they can stop for a break at any point in the interview if they 
need to do so, and that they can withdraw from participation at any point 
 demographic details – name and age 
 
Interview questions: 
 Please could you tell me about your experiences of treatment so far?   
 
 How did you find the transition between the surgical team and the oncology team? 
 How have you coped with this? 
 Positive aspects?  
 Negative aspects? 
 
 How were you prepared for further treatment following your surgery? 
 What were you were told  
 How were you told this? 
 How satisfied were you with this information? 
 
 Can you tell me about your experiences of communicating with the different 
professionals involved in your treatment so far?  For example, the surgeon, the 
breast care nurse, the oncologist, the GP. 
 Have there been any differences between these consultations? 
 In what ways have they been different? 
 Have these experiences impacted on your expectations of your treatment?   
 
 How have your expectations of treatment changed as it has progressed?   
 
 What were/are your expectations and feelings about receiving chemotherapy or 
radiotherapy? 
 What are these expectations based on? 
 Have you discussed these with anyone? 
 
 What do you think about the information you have received about your care from 
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the people involved in your treatment? 
  Before the breast surgery 
 After the breast surgery 
 When you came to the Beatson for the first time 
 What information would be most useful to you and when would it be most 
helpful to receive that information? 
 
 Have you used any other sources of information to find out about any of your 
treatment?  
 If so, what are they? 
 How did you come to find these – for example, your own research, 
signposted by healthcare professionals, other patients etc. 
 
 Are there any communication issues you see as important for women in a similar 
situation? 
 
 Is there anything I haven't asked you about that you think it is important that I 
should know about? 
 
Examples of general prompts that will be used throughout the interview: 
 “Can you tell me a bit more about that?” 
 “What was that like?” 
 “How did it make you feel?” 
 “Can you give me an example?” 
 “What do you mean by … ?” 
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Appendix 13: Excerpt from interview 2 with Lucy (pseudonym) 
 
Emerging 
Themes 
Original Transcript Exploratory Comments 
 
Nurse’s role 
 
 
Shock 
 
Emotional 
response to 
information 
 
Supportive others 
 
 
 
 
Knowing enough 
 
Side effects 
 
Uncertainty 
 
Information 
unfolding 
 
 
 
 
Nurse’s role 
 
 
 
 
Anxiety about side 
effects 
 
Minimising the 
possibilities 
 
Doctor reassures 
 
 
 
 
 
Side effects 
 
Knowing enough 
 
So, em, so then the breast nurse takes 
you away after the doctor speaks to 
you then you get asked loads of 
questions.  It’s quite good when you 
have somebody else there because 
[husband] was asking things.  Cause I 
was – she was just telling me things 
and I was thinking “right, okay, okay, 
okay” [laughs].  Just aye that’s fine, 
but he was maybe thinking on things 
that I wasn’t thinking to ask.  He’d 
asked about hair loss and all different 
things.  And they just tell you straight, 
yeah that you’ll lose your hair and 
different things so you kinda go away -  
You know some bits will be tough but 
you don’t know everything I don’t 
think until you come then for your – 
My first appointment here, which was 
a couple of weeks ago now.  It was 
just, it was all just about information, 
it wasn’t starting.  Em so I went in to 
see Dr [oncologist] first and she 
explained all about chemo and why 
you need it and what it does em 
[pause] the effects that it can have.  
She went through all your you know, 
your height and your weight and all 
this sort of stuff.  Ehm then you go and 
you see another breast care nurse after 
that and she goes through more in 
detail.  They get you a leaflet with all 
the different side effects but 
everybody’s different so you can’t  -  
No two people will maybe have the 
same experience, you know, so some 
people are sick, some people are 
normal.  But Dr [oncologist] told me 
they always try to, when they’re 
giving you the different types, if 
you’re not well with one particular 
type they will change it.  It’s not like 
before, they’ve come on leaps and 
bounds and what they’ll do is they’ll 
change it to try and suit you 
particularly.  Em, so they told me all 
about that and hair loss and different 
things [pause] and the other nurse 
Nurses role – nurses add to 
what doctor says, validates, 
reassures. 
 
 
 
 
Shock stops her from fully 
engaging with the 
information. 
 
Factual information given 
upfront. 
 
Hair loss most salient.  
Other side effects seem non-
specific. 
 
Information unfolds – you 
find out more as you go.  
Doesn’t seem to be a 
problem for her. 
 
 
Pause - side effects seem 
hard to think about 
 
Nurse adds to what doctor 
tells you – backs up, 
reassures. 
 
Receiving information 
 
Side effects might not 
happen to her – minimising 
possibility, staying hopeful. 
 
 
Hearing the reassuring 
information 
 
Expectations of 
chemotherapy – what it was 
like in the past. 
 
Pause – are side effects hard 
to think about?  
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Relationship with 
staff 
 
 
 
 
 
 
 
 
 
 
Knowing enough 
 
Information 
unfolds 
 
 
Looking ahead 
 
Getting through it 
 
Coping with 
uncertainty 
 
 
 
 
 
Managing 
information 
 
 
Coping 
 
 
 
 
 
 
 
basically it was just em she went 
through everything with a fine tooth 
comb and then gave me like a list of 
phone numbers and told me about 
yourself and she takes you round to 
see the chemo suite and where you’ll 
sit and that.  So I got bloods taken that 
day and that was great, it was very 
quick and painless, because some 
people can -  I’ve had blood taken 
quite a few times and some people are 
better than others [laughs] trying to 
find your veins you know.  I think 
today I’m getting it through my hand 
so that’s okay cause my hands are 
really veiny but my arms aren’t veiny 
but em -  So that’s – that’s it, she 
showed me round, I got my bloods 
taken then and she says that’ll do me 
for today and she explained then that 
what they’ll do after today is they’ll 
give me em – it’ll be every three 
weeks for six – I’ll be getting six 
sessions so that’ll be eighteen weeks 
and what’ll happen is three to four 
weeks after the last session then I’ll 
get my surgery done.  Em so I met the 
plastic surgeon and he was – he was 
lovely, in the Western.  So we’ve had 
that whole em -  Talked about different 
reconstruction types you can have and 
em [pause] he – he was explaining, he 
gives you the pros and cons of it all 
and you get a book to take home and a 
DVD which we haven’t watched yet 
cause I haven’t -  I’ve kind of flicked 
through the book but I thought “Och 
nearer the time”.  Cause basically 
there’s a choice of you can either get it 
taken off your back or your stomach or 
you can get an implant in.  And he tells 
you all the pros and cons of them all 
but you have to go away and look and 
decide what’s best for you.  But also if 
you want it taken from your stomach 
it’s all to do with your blood vessels so 
I had another MRI last week and that’s 
for, for him, for forward thinking if I 
want to get it taken from my stomach 
so that they can see what your blood 
vessels are like and stuff.   
 
 
 
 
 
Knowing who to contact 
 
 
 
 
 
 
 
 
Some uncertainty 
 
 
 
Knowing enough about 
what to expect. 
 
Small details make a 
difference 
 
Timescales – she finds 
certainty in the uncertainty. 
 
Looking ahead – contrast to 
taking it a day at a time. 
 
 
 
 
 
 
She chooses what to read 
and when.  Controlling the 
information. 
 
Staying present – thinking 
about the here and now. 
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Proposal Title  A qualitative investigation of the experiences of women with breast cancer 
between surgery and adjuvant chemotherapy 
 
Word Count  3809 (not including appendices) 
 
Date of Submission 23rd June 2014 
 
Version Number  5 
 
 
Abstract 
 
Background 
Research shows that communication with professionals is key in cancer care.  Difficulties 
with communication have been associated with increased psychological distress.  Women 
with breast cancer often report high levels of unmet need in terms of information and 
communication.    Research is further complicated by the fact that patients often receive 
treatment from a number of professionals in different settings. 
 
Aims 
This study aims to gain insight into the experiences of women with breast cancer of their 
transition from surgical to adjuvant chemotherapy.  Of particular interest are the 
expectations women have of chemotherapy, and how these expectations are formed. 
 
Method 
Participants will be primary breast cancer patients who have undergone surgery and are 
scheduled to receive adjuvant chemotherapy.  A qualitative design will be used and data 
will be gathered through use of semi-structured interviews.  Interviews will be analysed 
using Interpretative Phenomenological Analysis (IPA). 
 
Applications 
The results will give insight into the experiences and needs of women with breast cancer at 
this point in the care pathway.  This could allow for further development of ways of 
assessing and meeting needs, and minimising distress at this time.  The results may also 
provide suggestions for further research.  
 
 
 
Introduction 
 
Much research has focused on the importance of communication and information-giving in 
cancer care.  This suggests that patients with cancer seek information as a means of coping 
with their illness (e.g. Van der Molen, 2000).  Indeed, the SIGN Guidelines (2013) for the 
treatment of primary breast cancer emphasise the importance of information provision to 
patients and their families.  The most common factors found to contribute to patients' 
overall satisfaction with care are level of information given and interpersonal relations 
between the patient and provider.  Satisfaction with care is associated with better co-
operation with treatment, which is associated with better clinical outcomes (Sandoval, 
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Brown, Sullivan & Green, 2006).  A literature review found that poor communication can 
have negative outcomes for patients, including poor engagement with treatment and 
increased psychological distress (Thorne, Bultz & Baile, 2005).  Sandoval et al. (2006) 
found the areas that were consistently rated as problematic by the patients with cancer in 
their study included: information about follow-up care, knowing the next step in treatment, 
and knowing who to go to with questions.  In addition, patients often show 
misunderstandings about their treatment, illness and prognosis.  This may be in part due to 
lack of clear communication or withholding of information (Jefford & Tattersall, 2002).  It 
seems therefore that information giving may help shape and form patients’ expectations of 
their treatment. 
 
Cancer care can be thought of as a trajectory or journey, comprising a number of stages.  
Some authors delineate five key stages, including diagnosis, end of primary treatment, 
remission, relapse, and palliative care (e.g. Morse & Fife, 1998).  Evidence suggests that 
the information and communication needs of patients vary at these different stages.  For 
example, a qualitative study examining the information needs of 6 patients with different 
cancers found that needs changed across the different stages of the cancer experiences, and 
that patients were less able to process information at certain times (Van Der Molen, 2000).  
Patients interviewed by Tsianakis et al. (2012) described feeling vulnerable at certain 
points in the care pathway.  Their experienced lack of continuity of care appeared in part to 
be related to this.   
 
 
Continuity of care 
 
Investigation of communication in cancer care is further complicated by the fact that 
patients often receive treatment from a number of professionals in a range of settings at 
different stages of treatment.  This may have a negative impact on patients’ experiences of 
continuity of care (Harley et al., 2009).   Continuity of care has been defined as 'the degree 
to which a series of discrete healthcare events is experienced as coherent and connected' 
(Haggerty et al., 2003; p. 1221).  They emphasise that continuity is about how individuals 
experience the services they receive; qualitative methods may therefore be especially 
suited to examining patients' experiences.  
 
A qualitative study by Nazareth et al. (2008) examined 7 patients’ experiences of 
continuity in cancer care at different transition points.  Communication between primary 
and secondary care, the role of different health professionals and administrative systems 
were found to influence continuity of care.  This study, however, was based on people 
living with colorectal and breast cancer, which does not allow for examination of potential 
differences between patients with different cancer types.   
 
 
Breast cancer 
 
Some studies have examined the communication needs and experiences of women with 
breast cancer across the care pathway.  Breast cancer is the most commonly diagnosed 
cancer in women in the UK.  The incidence of breast cancer in Scotland is 127.1 people per 
100,000 (Cancer Research UK, 2013).  The main treatments are surgery, chemotherapy, 
radiotherapy, hormone treatment and biological therapy.  These can be used in isolation or 
in combination. 
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Graydon et al. (1997) used a questionnaire to assess the information needs of three groups 
of women with breast cancer at different stages in treatment (surgery, chemotherapy and 
radiotherapy).  Each group reported a strong need for information, with no significant 
differences between the groups.  A cross-sectional questionnaire based study by Raupach 
and Hiller (2002) looked at the information needs of a sample of 266 women with breast 
cancer between 6 and 30 months since diagnosis.  They found a continued high need for 
information about breast cancer issues regardless of time since diagnosis; their results also 
suggested that this need was often unmet, and that information giving decreased over time.  
In contrast, a longitudinal study by Vogel, Bengel and Helmes (2008) found that the 
women with breast cancer in their study (n = 135) reported the highest information needs 
at the beginning of treatment, compared to 3 and 6 months follow-up.  
 
Other studies have adopted a qualitative approach.  Thomsen and colleagues (2007) assert 
that questionnaire based studies of communication can often show a positive response bias, 
and may constrain the responses people give on a topic.  They interviewed 15 women with 
breast cancer about specific positive and negative communication experiences from their 
treatment 3 months after completion of adjuvant chemotherapy.  Information giving and 
the meeting of emotional needs were key themes arising from the analysis.  The authors 
note that the relatively long gap between the end of treatment and interview, however, may 
have led to recall bias.  Stephens et al. (2008) interviewed 200 women newly diagnosed 
with breast cancer who had recently received surgery, with the aim of identifying women’s 
needs and concerns at this time.  They identified a number of needs including social, 
emotional, physical and spiritual needs.  Participants also identified anxiety about possible 
future treatments as a concern.  
 
Qualitative and quantitative studies reveal conflicting results with regards to breast cancer 
patients' experiences of communication and information giving.  Some studies have used 
relatively heterogeneous samples (e.g. a mixture of stages and types of cancer), which may 
mask differences between patients with different cancers.  Some studies have waited until 
women have completed treatment to ask about their overall experiences.  Retrospective 
recall may obscure potential differences across the cancer trajectory.  Reporting 
experiences could also be affected by recall bias or by the outcome of treatment.  Birchall, 
Richardson and Lee (2002) suggest that the complexity of patient experiences may not be 
adequately captured by questionnaires.   
 
 
Adjuvant treatment 
 
Fiszer and colleagues (2013) recommend that studies should attend to specific times in the 
breast cancer journey, to gain a dynamic understanding of women's needs at different 
stages.    Some research has examined the particular information needs of women with 
breast cancer undergoing adjuvant treatments.  Lerman et al. (1993) surveyed 97 women 
after surgery but before adjuvant treatment, and 3 months later.  They found that most 
patients experienced difficulties with comprehending information and asking questions 
prior to adjuvant treatment.  More communication problems at the first time point were 
associated with greater distress at follow-up.  It has been suggested that information 
provision can reduce stress associated with adjuvant treatments (Adams, 1991).  
 
A qualitative investigation of the information needs of 51 patients with mixed cancer types 
(including breast cancer) and 14 of their spouses, with regard to the side effects of 
chemotherapy and radiotherapy, suggested that patients generally wanted as much 
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information as possible about the process of treatment and possible side effects.  The 
difficulties reported with getting this included access to and relationships with healthcare 
providers, difficulties retaining information, and too much information to digest (Skalla et 
al., 2004).   
 
Several studies have examined the specific information needs of women undergoing 
radiotherapy.  A literature review (Sutherland, 2014) found that women’s needs change 
over the course of treatment, and that these needs are not always met.  There has been less 
investigation of the needs of women undergoing adjuvant chemotherapy.  Evidence 
suggests that patients receiving chemotherapy experience considerable emotional distress 
(DiLorenzo et al., 1995).  The highest level of distress has been found to occur prior to the 
first infusion of chemotherapy, perhaps because of patient expectations about treatment 
(Jacobsen, Bovberg & Redd, 1993).  It is unclear exactly how these expectations are 
formed and how women's experiences up until this point may have impacted on their 
expectations. 
 
 
West of Scotland Context 
 
In the West of Scotland women diagnosed with breast cancer are usually seen by their 
surgeon first.  Following surgery they are under the care of Beatson West of Scotland 
Cancer Centre (BWoSCC) for adjuvant treatment.   Communication and information 
sharing may be particularly important during this period as these may impact on women's 
expectations of adjuvant treatment and their subsequent engagement with treatment.  
Women's experience of transition between the two phases of treatment is therefore of 
interest.  The BwoSCC serves a geographically diverse population, which may also impact 
on the experience of transitions of care – e.g. through patients travelling for treatment.  To 
the best of the author's knowledge, no studies have examined transitions in cancer care in 
Scotland.  
 
In summary, research consistently suggests that information giving and communication are 
important in cancer care for a number of reasons including minimising patient distress and 
improving engagement with treatment.  Difficulties with communication may have 
psychological consequences for patients.  Patients also have contact with a number of 
professionals over the course of treatment and care pathways can be complex.  It seems 
likely that experiences of communication with differ at each time point.  Closer attention to 
different points in the cancer journey is therefore warranted as these factors may impact on 
patients’ expectations of and engagement with further treatment. 
 
 
Aims / Objectives 
 
The proposed study aims to gain insight into the experiences of women with breast cancer 
of their transition from surgical treatment to adjuvant chemotherapy.  It will explore their 
perceptions of communicating with the different professionals involved in their care in 
order to gain more detailed information about their needs between these stages of 
treatment.  Of particular interest are the expectations women have of adjuvant 
chemotherapy, and how these are formed. 
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Plan of Investigation 
 
Design 
 
This study will take a qualitative approach to understanding women's experiences of the 
period between surgery and adjuvant treatment, using Interpretative Phenomenological 
Analysis (IPA).  Smith et al. (1999) suggest that IPA is particularly appropriate for health 
psychology research.  IPA involves 'the detailed examination of personal lived experience, 
the meaning of that experience to participants and how participants make sense of that 
experience' (Smith, 2011, p. 9).  IPA also emphasises the role of interpretation by the 
researcher during analysis.   
 
 
Participants 
 
There are a number of different care pathways for patients, depending on type and stage of 
cancer and treatment options.  A purposive, well-defined homogeneous sample will be 
recruited in terms of type of breast cancer and treatment pathway.  This will allow detailed 
examination of similarity and variability within the sample (Smith et al., 2009).  The 
sample will consist of women with early breast cancer who are treated initially with 
surgery and are scheduled to receive adjuvant chemotherapy. 
 
 
Inclusion and Exclusion Criteria 
 
Inclusion criteria will include women with primary breast cancer (Stage I or II) who have 
had surgery and will receive adjuvant chemotherapy.  Exclusion criteria will include: 
 
 patients under 30 years old – there is a steep increase in age-specific 
incidence rates from the ages of 30 – 34 onwards (Cancer Research UK, 
2014).  This will allow a more homogeneous sample to be recruited. 
 those for whom English is not their first language 
 women with a prior history of cancer   
 those who have received neo-adjuvant chemotherapy   
 men diagnosed with breast cancer, as they represent a very small percentage 
of cases 
 women with ductal carcinoma in situ (DCIS), as research suggests that the 
experiences of these patients may be different (e.g. Kennedy et al., 2012) 
 
 
Recruitment Procedures 
 
Women will be identified by their oncologist or their named nurse at their first or second 
oncology appointment at the BWoSCC following confirmation of their adjuvant treatment 
plan.  Patients identified as suitable will be given an information pack.  Potential 
participants will then complete a consent form giving permission for the researcher to 
contact them about the study (see Appendix A). 
 
Given that this research will involve women whose physical health may be compromised, 
telephone interviews will be offered to all potential participants.  It has been suggested that 
telephone interviews could result in the loss of non-verbal information, which could impact 
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on data analysis; telephone interviews may, however, allow participants to feel comfortable 
and to disclose sensitive information (Novick, 2008).  Sturges and Hanrahan (2004) found 
no significant differences in data quality between telephone and face to face interviews. 
 
 
Research Procedures 
 
Interviews will take place on a one-to-one basis and will last for approximately one hour.  
Participants will be reminded before starting, of the purpose of the interview and their right 
to withdraw at any point if they so choose.  The schedule will be semi-structured and topic 
guide will be developed to facilitate the interview (Appendix B). Relevant background 
research and discussion with supervisors and clinicians was used to develop the interview 
guide.  Prompts will be used to encourage participant elaboration on topics.  A non-
directive approach will be adopted by the interviewer.  Interviews will be recorded and 
transcribed verbatim, then checked for accuracy and completeness.  All interviews will be 
anonymised for references to person or place. 
 
 
Data Analysis 
 
Interviews will be analysed using IPA.  Transcription and analysis of data will begin 
following the first interview to help inform future interviews.  A sample of interview 
transcripts will be analysed blind by the academic supervisor to ensure the plausibility 
(Smith et al., 2009; p.80) of the analysis.  Once the first 2 -3 interviews have been 
conducted they will be transcribed and reviewed with the project supervisors to ensure that 
the topic guide is eliciting the right sort of material.  The topic guide will then be reviewed 
if necessary.  Data from these interviews will be included in the final analysis. 
 
The first stage of analysis, as described by Smith et al. (2009), involves reading the 
transcript several times to become as familiar as possible with the data.  In stage two, 
anything of interest in the transcript will be noted.  Some of these notes will be descriptive 
comments which describe or summarise the participant's account.  Other notes may explore 
the participant's use of language.  There may also be some initial interpretations of the data 
at this stage.  The third stage of analysis involves the development of emergent themes 
from the initial notes.  These themes will be given a title or phrase to capture the essence of 
the theme.  In stage four, the research will attempt to make connections across the 
emergent issues.  These four stages will be carried out with each interview transcript.  
Patterns across cases will then be explored. 
 
 
Justification of Sample Size 
 
Power calculations are not appropriate for qualitative research because sample size is not 
pre-determined.  In contrast to quantitative studies, generalisability is not the aim of 
qualitative research; rather, the goal is to generate detailed accounts of individual 
experience.  Between 4 and 10 interviews will be sought in line with Smith, Flowers and 
Larkin (2009), who state that this is appropriate for research for a professional doctorate.  
Discussion with clinicians at the BWoSCC indicates that 2 women per week would meet 
the inclusion criteria for the study.   
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Settings and Equipment 
 
Clinic rooms in BWoSCC will be used for interviews.  Equipment required will include a 
digital voice recorder, a telephone recording device for telephone interviews and a 
computer for transcription of interviews.  Telephone interviews will take place in a private 
room in the NHS Greater Glasgow & Clyde premises where the researcher is on 
placement. 
 
 
Health and Safety Issues 
 
Researcher safety issues 
 
Interviews will take place at the BWoSCC during working hours when other staff will be in 
the building.  Local safety procedures will be adhered to.  If any participants choose a 
telephone interview a private office will be used. 
 
 
Participant safety issues 
 
Participants will have undergone surgical treatment and as such their physical health may 
be compromised.  In addition it may be necessary to interview some participants after their 
chemotherapy has started, because of the time scales involved in treatment.  The researcher 
will seek to provide a comfortable environment for interviews.  Telephone interviews will 
be offered where travel time or physical discomfort would make face to face interviews 
difficult.  It is also recognised that this study will involve the discussion of potentially 
distressing topics for participants.  If participants become distressed during interviews this 
will be managed in a supportive manner by the researcher.  Participants will be reminded 
of their right to withdraw from the research at any stage, or to take a break and continue 
when they are comfortable doing so.  Participants who wish to seek psychological support 
will be advised of the referral process.  If participants raise issues about their medical care 
they will be advised to speak to their named nurse. 
 
 
Ethical Issues 
 
Applications will be submitted to the West of Scotland Ethics committee and the Beatson 
Clinical Trials Executive Committee for ethical approval prior to data collection.  Written 
information will be provided to all participants and they will have the opportunity to ask 
questions.  Informed consent will be sought from participants.  Participation in the study 
will be voluntary and participants will have the right to withdraw at any time without this 
impacting on their on-going medical care in any way.  Data will be held in line with NHS 
GGC policy and the Data Protection Act.  Data will be held securely on an NHS GGC 
computer or on a University laptop encrypted to NHS standards.   
 
 
Financial Issues 
 
Recording equipment, including a digital voice recorder and telephone recording device, 
and transcription equipment is available from the University.  There will be costs of 
printing and posting information sheets (Appendix C). 
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Timetable 
 
April 2014 – Submit major research proposal to course 
August 2014 – Submit application to ethics committee 
November 2014 – Begin data collection 
November 2014 – March 2015 – Continuing data collection and analysis 
March – June 2015 – Write up 
July 2015 – Submit major research paper to course 
 
 
Practical Applications 
 
The results of this study will provide an in-depth understanding of the experiences of 
women with primary breast cancer of the transition between surgery and adjuvant 
chemotherapy in the West of Scotland.  This will provide a greater understanding of 
women’s needs at this point in the care pathway.  This could allow for further development 
of ways of meeting these needs and minimising distress at this time.  This could also help 
inform further development of tools to assess patient needs and staff communication styles.  
The results of this study may also provide suggestions for further research.  A plain English 
summary is provided in Appendix D. 
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